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CHAPTER 1: THE STUDY PROBLEM 
Introduction 
 In 1993, the National Adult Literacy Survey reported that more than 40 million 
Americans were functionally illiterate, meaning that they could not perform the basic reading 
tasks necessary to function fully in society (Kirsch, Jungeblut, Jenkins, & Kolstad 1993).   
Although this survey did not include health-related items, these findings suggested that many  
Americans—approximately 43%—were unable to read and comprehend essential information 
they would likely encounter when seeking health care (Baker et al., 2002).   
 The 2003 National Adult Literacy Survey indicated that literacy rates in the United States 
remained much the same (Kutner, Greenberg, & Baer, 2006).  Nearly 90 million adults—almost 
half of all adults in the country—lack the literacy skills needed to effectively function in the 
present U.S. health system (Nielsen-Bohlman, Panzer, & Kindig, 2004).  
 In its report entitled Health Literacy: A Prescription to End Confusion, the Institute of 
Medicine (Nielsen-Bohlman, et al., 2004) adopted Ratzan and Parkers' (2000) definition of 
health literacy as being "the degree to which individuals have the capacity to obtain, process, 
and understand basic health information and services needed to make appropriate health care 
decisions" (p. 2).  In discussing health literacy, the Institute of Medicine emphasized that little 
attention is given to whether patients are able to comprehend their condition and treatment, 
to make the best decision for their care, and to take the correct medication in the right dose 
and at the right time.  Increasingly, the healthcare system in the U.S. imposes complex 
demands on adults whereby they are asked to assume new roles in seeking out health 
information, understanding rights and responsibilities, and making healthcare decisions for 
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themselves and others.  Underpinning these demands are assumptions about patients' abilities 
and skills (Nielsen-Bohlman, et al., 2004). 
 Today, many patients are living with chronic conditions that require ongoing proper use 
of medications.  In fact, more than one in four Americans have multiple (two or more) 
concurrent chronic conditions, including asthma, diabetes mellitus, heart disease and 
hypertension (Anderson, 2010).  To properly manage their chronic conditions, patients need to 
know why they need to take their medications, how their medications work and how to 
properly use or administer their medications.  Studies have shown that patients with limited 
literacy have a poorer understanding of prescription medication names, indications for use, and 
instructions (Davis, Wolf, Bass, Tilson, et al., 2006; Kalichman, Ramachandran, & Catz, 1999; 
Wolf et al., 2005). Limited literacy also been associated with drug therapy problems (e.g. 
duplicate medications, adverse effects) and poor adherence by the patient to a particular drug 
therapy (Knapp-Dlugosz, 2008). 
 At the core of the pharmacy profession is the improvement of health outcomes through 
the proper use of medications (Brown, 2006).  Pharmacists remain among the most accessible 
healthcare providers and can be one of the first healthcare providers to recognize that a patient 
has lower literacy (Youmans & Schillinger, 2003).  As such, knowing the health literacy level of 
patients and the association of lower levels of literacy to health outcomes have become 
increasingly important to pharmacists.  To adequately prepare future pharmacists, colleges of 
pharmacy should include training with regard to patient-centered approaches to health care, 
which include the relationships between literacy and health (Youmans & Schillinger, 2003). 
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Problem Statement 
  This study was undertaken as a step in furthering understanding the relationships 
between health literacy and specific variables in a population of persons taking medication for 
the chronic diseases of asthma, cardiovascular disease/hypertension, depression/anxiety and 
diabetes mellitus so that educational materials may be developed for pharmacy education.   
 In particular, this study was guided by the research question: Do the subject 
characteristics health literacy, gender, race, age, and levels of education influence clinical 
outcomes of patients with asthma, diabetes mellitus, cardiovascular disease/hypertension, and 
depression/anxiety?   
Purpose of the Study 
 The purpose of this study was to examine the extent to which health literacy is 
associated with different demographic factors (e.g. gender, race, educational level) and the 
extent to which health literacy is associated with clinical outcomes for patients with asthma, 
diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety in a well-
defined, self-insured university population.  
  The primary aim of this study was to test the hypothesis that limited health literacy, 
alone or in combination with other factors is associated with certain clinical outcomes of 
patients with asthma, diabetes mellitus, cardiovascular disease/hypertension, and 
depression/anxiety.  The findings of this study will be used in the development of educational 
materials for pharmacy education.  
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Aims and Hypotheses 
 As described more fully in Chapter 3, the research question was explored using the 
following aims and hypotheses: 
1. To evaluate the association of health literacy with the following demographic 
factors: gender, race, age, and level of education. 
H1a: Limited health literacy is associated with higher age and lower levels of 
education. 
H1b: Limited health literacy is not associated with gender or race.  
2. To evaluate the association of health literacy with clinical outcomes of patients with 
asthma, diabetes mellitus, cardiovascular disease/hypertension, and 
depression/anxiety. 
H2a: Limited health literacy is associated with clinical outcomes of asthma, diabetes 
mellitus, cardiovascular disease/hypertension, and depression/anxiety.  
H2b: Limited health literacy is associated with higher body mass index (BMI), higher 
blood pressure, higher fasting blood glucose levels, and dyslipidemia.  
H2c: Limited health literacy is associated with lower medication adherence. 
H2d: Limited health literacy is associated with the need for patient education.  
H2e: Limited health literacy is associated with sub-optimal medication regimens. 
3. To construct a logistical regression model to determine independent predictors of 
health literacy from among the variables considered in research questions 1 and 2, 
above.  
H3: Each of the following will independently predict health literacy: gender, race, 
age, level of education, health outcomes of asthma, diabetes mellitus, 
cardiovascular disease, and depression/anxiety, lower medication adherence, 
increased need for patient education, and sub-optimal medication regimens.  
Data Sources 
  Relationships between the study variables: health literacy, and health outcomes of 
patients with asthma, diabetes mellitus, cardiovascular disease and depression, as well as 
potential co-variates of age, gender, race, and education level, will be tested using data 
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previously collected as a part of a university heath wellness Medication Therapy Management 
program. 
Definition of Terms 
 To ensure consistency in the implementation and analysis of the study, key terms and 
study variables were defined as follows:  
 Adherence is the extent to which a person's behavior (in terms of taking 
medications, following diets, or executing lifestyle changes) coincides with medical 
or health advice (Meichenbaum & Turk, 1987).  For this study, medication adherence 
was measured by patient interviews and the use of the Modified Morisky Scale 
(Morisky, Green, & Levine, 1986). 
 Asthma is an inflammatory lung disease (Poureslami et al., 2007).  Asthma is 
considered a common chronic disorder of the airways which is characterized by, 
among other things, recurring airflow obstruction (National Heart, 2007). For 
purposes of this study, asthma was determined by participants' self-report of being 
diagnosed with asthma.  The level of asthma control was measured by the 
administration of the Asthma Control Test (QualityMetric Incorporated, 2002).  
 Body Mass Index (BMI) is a ratio used to describe patient's weight based on patient's 
height.  It is calculated by dividing a patient's weight by the patient's body surface 
area (height in meters squared).  A BMI of 25.0-29.9 is considered overweight and a 
BMI of 30.0 or above suggests obesity and risk factor for diabetes mellitus and 
cardiovascular disease.  
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 Cardiovascular disease affects the heart and blood vessels.  Cardiovascular disease 
includes hypertension and is associated with dyslipidemia.   Control of 
cardiovascular disease was measured by measuring participants' blood pressure, 
BMI, and blood glucose levels.  
 Chronic illnesses (or chronic diseases) are conditions that last a year or more and 
require ongoing medical attention and/or limit activities of daily living (Warshaw, 
2006). 
 Depression is a mental state characterized by a pessimistic sense of inadequacy and 
a despondent lack of activity.  Depression/ anxiety is often associated with chronic 
diseases including asthma, diabetes and cardiovascular disease. For purposes of this 
study, depression/anxiety was determined by participants' self-report of being 
diagnosed with depression or anxiety.  The level of a patient's depression was 
measured by the Zung Self-Rating Depression Scale (Zung, 1965). 
 Dyslipidemia is a condition marked by abnormal concentrations of lipids or 
lipoproteins in the blood.  For purposes of this study, dyslipidemia was determined 
by participants' self-report of being diagnosed with dyslipidemia.  The level of a 
patient's dyslipidemia was measured by the administration of a blood test 
measuring, in milligrams per deciliter (mg/dl): triglycerides, total cholesterol (TC), 
high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol. 
Dyslipidemia is associated with diabetes mellitus and can lead to cardiovascular 
disease. 
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 Diabetes mellitus is a polygenic disease characterized by abnormally high glucose 
levels in the blood.  For purposes of this study, diabetes mellitus was determined by 
participants' self-report of being diagnosed with type 1 or type 2 diabetes and/or the 
administration of a blood glucose test after the patient fasts for at least eight hours 
(a fasting blood glucose test).  There are three levels of blood glucose: normal, pre-
diabetic and diabetic. Patients with diabetes mellitus often also have cardiovascular 
diseases.  
 Functional health literacy is a measure of a person's ability to perform basic reading 
and numeric tasks in the healthcare context, such as reading medication labels and 
insurance forms and performing mathematical tasks associated with taking 
medications (Ad Hoc Committee on Health Literacy for the Council on Scientific 
Affairs, 1999). 
 Health literacy is the degree to which individuals have the capacity to obtain, 
process and understand basic health information and services needed to make 
appropriate health decisions (Ratzan & Parker, 2000).  For purposes of this study, 
health literacy was determined by the participants' score on The Newest Vital Sign 
(Weiss et al., 2005) and  will be categorized as having adequate health literacy or 
limited health literacy.  
 Health outcomes are changes in a patient's health status resulting from healthcare 
service.  These include mortality (death), morbidity (increased or additional illness), 
functional status, and quality of life (Donabedian, 1978). Health outcomes also 
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include relief of symptoms, adverse drug interaction, medication adherence and the 
need for patient education  (Mullins, Baldwin, & Perfetto, 1996).   
 Hypertension is high blood pressure measured in systolic over diastolic blood 
pressure.  For purposes of this study, hypertension was determined by participants' 
self-report of being diagnosed with hypertension and/or having abnormally high 
blood pressure. Hypertension is considered a cardiovascular disease and is often 
associated with diabetes mellitus.   
 Literacy level is the assessment of grade level reading ability. It can be measured by 
instruments such as the Rapid Estimate of Adult Literacy in Medicine (REALM) (Davis 
et al., 1993).  Ninth-grade reading ability and higher is considered standard literacy 
and eighth-grade reading ability and lower is considered low literacy.  
 Medication Education for purposes of this study included the need for patient to 
receive guidance and/or training from a pharmacist on the following: proper use of 
medication, patient self-care, medication adherence, use of monitoring devices, 
disease state management and lifestyle changes. 
 Medication Therapy Management (or MTM) describes the services provided by 
pharmacists to patients under which optimization of medication is used for the 
improvement of health outcomes.  For purposes of this study, the Medication 
Therapy Management in Pharmacy Practice: Core Elements of an MTM Service 
Model (version 2.0) (American Pharmacists Association & National Association of 
Chain Drug Stores Foundation, 2008) served as the basis of MTM discussions.  
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 Sub-Optimal Medication Regimen for purposes of this study included sub-optimal 
medication regimen included patients: needing additional drug information; having 
been prescribed medication(s) that were insufficient or excessive in dose or 
duration; having been prescribed medication(s) that are ineffective;  needing more 
cost effective drug option(s); under using medication(s); receiving unnecessary drug 
therapy;  having poor drug administration technique;  using drugs excessively; 
requiring additional laboratory monitoring; for whom additional drug therapy is 
needed; and that have had adverse drug event(s). 
Assumptions 
The following assumptions were made for this study: 
1. The Asthma Control Test is a valid and reliable instrument that measures a patient's 
control of asthma. 
2. The Modified Morisky Scale is a valid and reliable instrument that accurately 
measures a patient's medication adherence. 
 3. The Newest Vital Sign is a valid and reliable instrument that accurately measures an 
 individual's health literacy level. 
 4. The Zung Self-Rating Depression Scale is a valid and reliable instrument that 
 accurately measures a patient's level of depression/anxiety.  
 5. The self-report items of age, years of education and race are accurate. 
 6. The self-report of being diagnosed with a particular disease(s) state is accurate. 
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Significance 
 This study sought to gain additional information on the complex relationships between 
the health literacy of patients with asthma, diabetes mellitus, cardiovascular disease and 
depression/anxiety, and patient variables including age, gender, race, and levels of education.  
Hundreds of studies have explored how patients' ability to read and comprehend healthcare 
information is associated with poor health outcomes (Wallace, 2010) and there have been 
pharmacist-led studies which have examined these same issues.  However, there have been 
few pharmacist-led MTM studies that have included the assessment of the health literacy of 
patients.  This study explores the relationship between the health literacy and the health 
outcomes of those patients with chronic diseases who took part in a MTM program 
administered as part of a university health wellness program.   
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CHAPTER 2: CONCEPTUAL FRAMEWORK AND LITERATURE REVIEW 
Introduction 
 This chapter introduces the conceptual framework that was used to guide the 
construction of the study, including the Health Literacy Model and the Medication Therapy 
Management Service Model.  After the discussion of these models, relevant research literature 
is presented on each of the study variables: health literacy, asthma, diabetes mellitus, 
cardiovascular disease/hypertension, and depression/anxiety. For the literature review, a 
comprehensive search of the literature was conducted using electronic search engines, 
electronic databases, reviews of bibliographies of published research and manual searches of 
journals and other publications.  A graphic representation of the models used in this study will 
be presented.   
Conceptual Framework 
 Although the significance of low functional literacy on health outcomes had been 
studied since the 1980s, it was not until 1995 that a landmark case highlighted the magnitude 
of this issue.  The case showed that up to two-thirds of patients seen in public hospitals in the 
United States were unable to comprehend key health information on how to take medication 
or how to schedule a follow-up appointment (Wallace, 2010; Williams, Parker, Baker, & al, 
1995).  As a result of this study and those that followed, in 2004, the Institute of Medicine 
sought to document the problem of health literacy in the United States and to describe its 
origins, consequences, and solutions.  As a result, Health Literacy: A Prescription to End 
Confusion was published (Health literacy: A prescription to end confusion, 2004). This 
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publication contained "Health Literacy Framework" and "Potential Intervention Points" (Figures 
1 and 2, respectively).  
 
Figure 1. Health Literacy Framework 
(Health literacy: A prescription to end confusion, 2004) 
 
 
Figure 2. Potential Intervention Points 
(Health literacy: A prescription to end confusion, 2004) 
 
 Figure 2 shows literacy as the foundation of health literacy and health literacy as the 
active mediator between individuals and health contexts (p. 32). Figure 2 illustrates the 
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potential influence on health literacy as individuals interact with educational systems, health 
systems, and cultural and social factors, and suggests that these factors could ultimately 
contribute to health outcomes and costs (p.4). Figure 2 also indentifies three major areas of 
potential intervention in effecting health literacy, namely culture and society, the health system 
and the educational system.  
 The Institute of Medicine suggests that the U.S. educational system offers a primary 
point of intervention in the improvement of literacy and health literacy (p. 142). In this section 
of the report, the committee includes recommendations for K−12 education, the adult 
education system, and education for health professionals.  With regard to healthcare 
professionals, the committee recommends that professional schools in health fields, including 
schools of pharmacy, incorporate health literacy into their curricula and areas of competence 
(Recommendation 5-6, 2004, p. 161).   
 It is upon this basis that this study was undertaken; the results of this study will be used 
to formulate educational materials for pharmacy education in the areas of health literacy and 
the improvement of health outcomes for patients with chronic diseases.   
 Before discussing the literature related to health literacy and chronic conditions that are 
addressed in this study (i.e. asthma, diabetes mellitus, cardiovascular disease, and depression), 
a brief history of pharmacy education and Medication Therapy Management (MTM) is 
presented, along with a review of selected laws involving pharmacists and MTM. 
Pharmacy Education in the United States 
 Historically, students in the United States wishing to become licensed pharmacists 
pursued baccalaureate degrees in pharmacy, generally through five-year programs.  A student 
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could (and can) attend a stand-alone college of pharmacy or a school of pharmacy housed 
within a university.  After decades of debate within the pharmacy community, in 1997, the 
educational requirements of pharmacy programs increased (Accreditation Council for Pharmacy 
Education, 2011).  Beginning with 2005, those wishing to become licensed pharmacists must 
now complete a Doctor of Pharmacy (Pharm.D.) professional degree.  Today, all pharmacy 
programs in the United States are professional doctorate programs.   
 Graduates who complete a Doctor of Pharmacy degree and wish to practice pharmacy 
in the United States must become licensed.  They must sit for and pass the North American 
Pharmacist Licensure Examination (NAPLEX).  State boards of pharmacy require licensure 
applicants from the United States to have graduated from an accredited Doctor of Pharmacy 
program to be eligible to sit for the NAPLEX.   
 In the United States, Pharm.D. programs are accredited through the Accreditation 
Council for Pharmacy Education (ACPE), founded in 1932 as the American Council on 
Pharmaceutical Education.  ACPE is an autonomous and independent agency whose board of 
directors is appointed by the American Association of Colleges of Pharmacy, the American 
Pharmacists Association, the National Association of Boards of Pharmacy and the American 
Council on Education.  ACPE's mission is "to assure and advance excellence in education for the 
profession of pharmacy"(preamble) (Accreditation Council for Pharmacy Education, 2011) in 
the United States, which it accomplishes, in great part, through its accreditation of U.S. schools 
of pharmacy.    
 In 2006, the ACPE revised its accreditation standards to include provisions mandating 
that schools of pharmacy include training in the patient-centered pharmaceutical care model 
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(Accreditation Council for Pharmacy Education, 2011).  This was the result of a paradigm shift 
that had taken place in the profession as pharmacists sought to expand their roles past the 
"mundane counting and pouring, licking and sticking" (Higby, 2010) (p. 112). Pharmacy students 
are now trained to be drug information specialists and medication counselors.  At the heart of 
being an effective medication counselor is the concept of patient-centered pharmaceutical 
care.   
Pharmaceutical Care 
   According to the American Pharmacists Association, the definition of pharmaceutical 
care is: 
a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist 
to work in concert with the patient and the patient's other health care providers to 
promote health, to prevent disease, and to assess, monitor, initiate, and modify 
medication use to assure that drug therapy regimens are safe and effective.  
 
 Under this definition, pharmaceutical care is a form of pharmacy practice that is patient-
centered rather than medication-centered.  Pharmacists are required to accept responsibility as 
direct patient-care providers and enter into a more formalized relationship with their patients 
for the explicit purpose of improving patient outcomes (Cipolle, Strand, & Morley, 2004).  This 
type of patient-centered pharmaceutical care often includes Medication Therapy Management 
services.  
Medication Therapy Management  
  Academy of Managed Care Pharmacy (AMCP) has indicated that, for Medication 
Therapy Management (MTM) to be effective, several things must occur, including: the 
medication must be prescribed at the correct dose and the proper duration; the patient must 
get the prescription filled and must be adherent to the therapy; patients must be monitored to 
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ensure that the best health outcomes are achieved, that the objectives of the therapy are being 
met, and that adverse events are minimized; and patients must be properly educated and 
counseled.  
 This is especially true for patients who are at high risk as a result of chronic conditions 
and/or complex medication regimens. MTM services greatly enhance patient care, leading to 
improved overall health, while at the same time decreasing healthcare costs by reducing 
improper medication use, preventing adverse drug events and supporting therapeutic goals 
(Academy of Managed Care Pharmacy, 2006). 
 Pharmacist-led medication therapy reviews have shown to reduce the healthcare costs 
for diabetic patients, including the reduction in physician visits and emergency department 
visits (Cranor, Bunting, & Christensen, 2003; Garrett & Bulmi, 2005).  Medication therapy 
reviews have also shown to reduce asthma-related emergency room/hospital visits and 
changes in asthma-related costs over time (Bunting & Cranor, 2006). 
 In 2004, eleven pharmacy organizations including the American Pharmacists Association 
(APhA), the American Association of Colleges of Pharmacy, and the National Association of 
Boards of Pharmacy achieved a consensus definition of MTM services as a distinct service or 
group of services that optimize therapeutic outcomes for individual patients (American 
Pharmacists Association & National Association of Chain Drug Stores Foundation, 2005).   
Building on this consensus definition, the APhA and the National Association of Chain Drug 
Stores Foundation developed a model framework for implementing effective MTM services in a 
community pharmacy setting.  This service model was later revised and memorialized in 
Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service 
17 
 
 
Model Version 2.0. (American Pharmacists Association & National Association of Chain Drug 
Stores Foundation, 2008). 
 The MTM service model in pharmacy practice 2.0 includes these five core elements: 
 Medication therapy review 
 Personal medication record 
 Medication-related action plan 
 Intervention and/or referral 
 Documentation and follow-up 
A diagram of the MTM Service Model is presented in Figure 3 below.  The "Medication Therapy 
Review" element of the model has been highlighted as this is the area of inquiry of this study.  
 
 
Figure 3. The Medication Therapy Management Core Elements Service Model 
 (American Pharmacists Association and The National Chain of 
Drug Stores Foundation, 2008) 
 A "Medication Therapy Review" includes a systematic process of collecting patient-
specific information, assessing medication therapies to identify medication-related problems, 
developing a prioritized list of medication-related problems, and creating a plan to resolve 
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them (p.344). The APhA and the National Association of Chain Drug Stores Foundation suggest 
that medication therapy reviews include interviewing the patient to gather data including 
demographic information, general health and activity status, medication history, and patient's 
thoughts or feelings about his or her conditions and medication use (including medication 
adherence) (American Pharmacists Association & National Association of Chain Drug Stores 
Foundation, 2008).   
 Additionally, as part of a medication therapy review, assessing a patient's health literacy 
level (Brown, 2006)—the education level of the patient, language differences, and other 
characteristics of patient's communication ability that could affect health outcomes—proves 
important.  This is especially true for patients with chronic diseases such as asthma, diabetes 
mellitus, cardiovascular disease/hypertension, and depression/anxiety which were the subjects 
of this inquiry. 
Laws associated with MTM services 
 An impetus for these organizations to develop a recognized model of MTM services was 
the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. 
This act, among other things, established Medicare Part D, which provides prescription drug 
coverage for Medicare beneficiaries (seniors and persons receiving Social Security Disability 
Insurance) through prescription drug plans. According to this law, all Part D plans must have a 
MTM program (section 1860-4[c][1][2]). MTM programs target Medicare beneficiaries who 
have multiple chronic diseases, are taking multiple drugs covered under Part D, and are likely to 
incur annual drug cost exceeding a certain level (differs by year). The Centers for Medicare and 
Medicaid Services (CMS) now require that all such MTM programs include an annual 
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medication review, a person-to-person consultation (face-to-face or by telephone) and a 
written summary ("Pharmacy educators utilize key partnerships to provide patient care," 2010). 
 This act also created unprecedented opportunity for pharmacists as the first federal law 
specifically authorizing direct payment of pharmacists for MTM services, without being 
"incident to" the services of a physician. In other words, pharmacist can now directly bill for 
MTM services under their own set of billing codes (Hogue & Bluml, 2009).  This recognizes the 
valuable role that pharmacists play in improving the health outcomes of patients, especially 
when it comes to MTM services.  
MTM and pharmacy education 
 These same opportunities provide challenges for pharmacy education.  MTM requires 
the development of problem-solving skills and improved communication capabilities on the 
part of pharmacy students.  To be effective, pharmacy students must be taught how to 
anticipate, prevent, and solve drug-related problems; identify which problems must be 
attended to first (in cooperation with the patient); develop action plans that include non-drug 
therapies; and be able to explain and justify these alternatives to patients, physicians, and third 
parties (e.g. insurance companies). This requires a different skill set from those needed to 
dispense medications (Berger, 2005, p.8).   
 To provide the requisite training for pharmacy students, educational materials about 
MTM services need to be developed for pharmacy education.  These materials should include 
the demonstration of the relationships between health literacy, MTM services and health 
outcomes of patients with chronic conditions.  
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  The following section presents relevant literature on health literacy and the 
relationships of health literacy on the health outcomes for patients with asthma, diabetes 
mellitus, cardiovascular disease, and depression. 
Health Literacy 
A two-year old is diagnosed with an inner ear infection and prescribed an antibiotic. 
Her mother understands that her daughter should take the prescribed medication 
twice per day.  After carefully studying the label on the bottle and deciding that it 
doesn’t tell her how to take the medication, she fills a teaspoon and pours the 
antibiotic into her daughter's painful ear (Parker, Ratzan, & Lurie, 2003). 
 
 While this may be an extreme case, it highlights the importance of health literacy to 
ensure appropriate health outcomes.  Health literacy can be defined as the degree to which 
individuals have the capacity to obtain, process and understand basic health information and 
services needed to make appropriate health decisions (Ratzan & Parker, 2000).  According to 
the World Health Organization, "health literacy represents the cognitive and social skills which 
determine the motivation and ability of individuals to gain access to, understand and use 
information in ways which promote and maintain good health"(World Health Organization, 
1998). Health literacy includes the ability to perform basic reading and mathematical tasks to 
comprehend and act on health information such as prescription labels, appointment cards, and 
hospital forms (Andrus & Roth, 2002). 
 Health literacy differs from general literacy, which refers to the basic ability to read, 
write, and compute, without regard to context in which the reading or writing occurs (Mayer & 
Villaire, 2007, p.17). Health literacy refers to how well a person applies a broad range of literacy 
skills in the context of health care (Mayer & Villaire, 2007)(p.3). Many people with otherwise 
acceptable general literacy may find it difficult to understand and act upon the concepts and 
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vocabulary used in health-related contexts; therein lies the difference, especially in patient 
populations with higher levels of education.  
 Presented with the issue of differing levels of health literacy among their patients, 
pharmacists need to be in the position to educate and counsel patients in a comprehensive 
way, identifying patients' level of understanding, and selecting appropriate educational 
materials (Rantucci, 2007, p.7). 
Health Literacy and Health Outcomes for Patients with Asthma 
 Asthma is a chronic inflammatory disease of the airways that affects more than 22 
million people in the United States.  According to the National Heart, Lung, and Blood Institute, 
in spite of recent advances in the detection and prevention of asthma, asthma accounts for 2 
million emergency visits per year and approximately 500,000 hospitalizations annually (National 
Heart, 2007). In 2002, direct costs were estimated at $9.4 billion, with additional costs of $4.6 
billion in indirect costs related to loss of work, loss of school days, and mortality (American Lung 
Association Epidemiology and Statistics Unit Research and Scientific Affairs, 2004). 
 One of the hypotheses of the proposed study is that inadequate health literacy is 
associated with clinical outcomes for patients with asthma, including the extent to which 
patients know how to appropriately administer their medication.  In order to effectively 
manage their asthma, patients must be knowledgeable about their disease and must be able to 
use metered-dose inhalers (MDIs) correctly.   In a study examining the relationship of health 
literacy to asthma knowledge and the ability to use metered-dosed inhaler, Williams, et al. 
(1998) surveyed 483 patients presenting themselves either to an emergency room department 
or routine care in a specialized asthma clinic. In accessing the patients' health literacy, they 
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used the Rapid Estimate of Adult Literacy in Medicine (REALM). To assess the patients' 
knowledge of asthma, they administered a 20-item oral questionnaire used in previous studies.  
Proficiency in the use of an MDI was measured by requesting patients to demonstrate their 
usual MDI technique of "taking two puffs" in the event of an asthma attack.   
 In this study, they found that only 27% of patients read at the high-school level, 
although two-thirds reported being high school graduates; 33% read at the seventh-to-eighth 
grade level, 27% at the fourth-to-sixth-grade level, and 13% at or below the third-grade level.  
They found that reading level was the strongest predictor of asthma knowledge in a 
multivariate analysis; in a multivariate regression analysis, reading level was the strongest 
predictor of MDI technique.  In sum, inadequate literacy was common and strongly correlated 
with poorer knowledge of asthma and improper MDI use.  
 In 2006, Mancuso and colleagues explored the association between health literacy and 
longitudinal outcomes in a cohort of asthma patients.  They assessed the extent to which health 
literacy and other variables were independently related to health outcomes, including physical 
activity which is of interest in the proposed study.  Patients within an urban setting were 
eligible for participation in the study if they required daily asthma medications, such as inhaled 
corticosteroids and were enrolled when they came in for scheduled office visits with their 
primary care physician.  Health literacy was measured with the Test of Functional Health 
Literacy in Adults (TOFHLA) and overall asthma-related quality of life was measured with the 
Asthma Quality of Life Questionnaire, a well-established scale measuring symptoms, activity 
limitations, and the effects of emotions on asthma. Resource utilization for asthma was 
measured by self-report of emergency room visits during three- month intervals.  
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 Of those who participated in this study, 82% had adequate health literacy, 8% had 
marginal health literacy, and 10% had inadequate health literacy. In subsequent analyses, the 
subjects were dichotomized into those with adequate health literacy (82%) and those with 
marginal/inadequate health literacy.  Although inadequate health literacy was associated with 
worse quality of life, worse physical function, and more emergency department utilization, in 
multivariable analysis, health literacy did not remain statistically significant with any of the 
measured outcomes.  
  In 1991 the National Asthma Education and Prevention Program, coordinated by the 
National Heart, Lung, and Blood Institute (NHLBI) published the Expert Panel Report: Guidelines 
for the Diagnosis and Management of Asthma, which it updated in 1997, 2002 and 2007 
(National Heart, 2007). Contained in these guidelines was the recommendation that patients 
receive education to help improve the physician-patient partnership in managing patients' 
asthma.  Noting that no studies to date had evaluated the extent to which inadequate health 
literacy served as a barrier to learn and retain asthma self-management skills (Berkman et al., 
2004), in 2005 Paasche-Orlow, et al. sought to examine the relationship between inadequate 
health literacy and difficulties learning and retaining instructions about discharge medications 
and appropriate MDI technique.  The extent to which inadequate health literacy is associated 
with the need for patient education is also the subject of this proposed study. 
 In exploring these variables, Paasche-Orlow, et al. recruited 73 adults who were 
hospitalized for severe asthma at two inner-city academic medical centers.  At hospital 
discharge, participants received intensive one-on-one, guideline-based written and oral 
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instruction about their asthma discharge regimen as well as appropriate MDI technique.  Health 
literacy was measured with the Short Test of Functional Health Literacy in Adults  
(S-TOFHLA) and participants were classified as having or not having inadequate health literacy. 
In accessing patients' understanding of asthma medications (including inhaled corticosteroids), 
the researchers developed an asthma knowledge scale.  MDI technique was measured by 
demonstration of the use of an MDI inhaler. In follow-up visits, these same items were re-
assessed.  Additionally, asthma symptom control was measured using the Asthma Control 
Questionnaire.  
 Of the 73 participants, 22% had inadequate health literacy. Before instruction, 
inadequate health literacy was associated with lower asthma medication knowledge and worse 
MDI technique (a form of medication adherence). However, inadequate health literacy was not 
associated with difficulty in learning or retaining instructions about discharge regimen nor was 
inadequate health literacy associated with difficulty in learning or retaining appropriate MDI 
technique.  The results of this study suggest that tailored patient education may reduce 
disparities in asthma self-management.  
MTM and health outcomes for patients with asthma 
 Exploring the theme of patient education and health outcomes for patients with 
asthma, in their 2006 study, Bunting & Cranor assessed the clinical, humanistic, and economic 
impact of a MTM program on adult patients with asthma living in and around Asheville, N.C. 
This study was modeled after an earlier well-documented program entitled the Asheville Project 
which examined a community-based pharmacist-driven diabetes care model.  (The Asheville 
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Project will be discussed under Health Literacy and Health Outcomes for Patients with Diabetes 
Mellitus, below.) 
  In their quasi-experimental, longitudinal pre-post study, these researchers recruited 
207 adult patients with asthma covered by two self-insured health plans—similar to the 
proposed study site. They examined the impact of asthma education and regular long-term 
follow-up by pharmacists, using scheduled consultations, monitoring, and recommendations to 
physicians. Asthma education was provided by specially trained community pharmacists in one 
or two individual one-on-one sessions, lasting 60-90 minutes each. 
 Patients were eligible to participate if they were covered by participating employers' 
health plans and had a diagnosis of asthma, regardless of baseline control or severity of 
disease.  This study was unique as patients were not specifically targeted because of history of 
emergency department visits, hospitalizations, or high utilization of health plan dollars.   
 Measured clinical outcomes included asthma severity, humanistic measures (i.e. how 
asthma was affecting their lives), direct medical care costs (e.g. emergency room visits and 
prescriptions), and indirect costs (i.e. cost to employer of lost work hours due to absenteeism) 
over a period as long as five years. However, it is important to note that the patients' health 
literacy level was not examined in this study.  
 The findings of the study were significant: All objective and subjective measures of 
asthma control improved and were sustained for as long as five years. Asthma severity lessened 
significantly, and emergency visits and hospitalizations significantly decreased.  Spending on 
asthma medications increased; however overall asthma-related medical claims decreased.  This 
26 
 
 
study is important as it shows the value of pharmacy-provided MTM services, including patient 
education as the same relates to health outcomes for those patients with asthma.  
 The above cited study emphasizes the integral role that MTM services can play in 
reducing overall healthcare costs and improving health outcomes of patients with asthma.  
What makes this study unique is that health literacy levels of MTM patient participants were 
measured to examine to what extent health literacy plays a role in predicting the health 
outcomes of patients with asthma. 
Health Literacy and Health Outcomes for Patients with Diabetes Mellitus 
 Societal changes in recent years have led to a dramatic increase in the prevalence of 
obesity among adults and children in the United States. These changes include increased food 
intake, nonhealthful foods, and physical inactivity.  In 2007, 25.6% of the adults in the United 
States were obese by self-report (Centers for Disease Control and Prevention).  Obesity is a 
major risk factor for cardiovascular disease, certain types of cancer, and type 2 diabetes 
(Centers for Disease Control and Prevention).  It is estimated that in 2010, diabetes affected 
25.8 million people in the United States or 8.3% of the U.S. population; medical expenses for 
those who have diabetes mellitus are more than two times higher than for people without the 
disease (Centers for Disease Control and Prevention, 2011).   
 Given the complexity of managing diabetes mellitus, health outcomes for adults with 
diabetes mellitus are better for those who can optimally incorporate self-management of their 
diseases into their daily lives (Sigurdardottir, 2005).  Diabetes care requires an informed 
individual who can seek, obtain, and comprehend information to engage in the management of 
his/her health (Morris, MacLean, & Littenberg, 2006).   
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 This study included patients with diabetes mellitus and helps determine if health literacy 
is a factor in the management of their chronic condition.  Along with levels of physical activity, 
measurements of diabetes management included blood pressure, body mass index (BMI), 
hemoglobin A1c (as an indication of glycemic control), triglycerides, and cholesterol levels.  The 
need for patient education in this population was also assessed.   
Studies on health literacy and diabetes mellitus 
 To date, results of studies examining the relationship of health literacy and health 
outcomes for patients with diabetes mellitus have been inconsistent.  In an early study, 
Williams (1998), examined the relationship between literacy and knowledge of chronic disease 
focusing on patients with diabetes mellitus and hypertension. Drawing subjects from two urban 
hospitals, the study enrolled 402 patients with hypertension and 114 patients with diabetes 
mellitus. The patients' literacy level were tested using the TOFHLA; their knowledge of their 
illness was assessed using 21 hypertension and 10 diabetes questions based on key elements in 
educational materials used in their clinics. Other health outcomes measured in the study were 
patients' levels of blood pressure and hemoglobin A1c.   
 These researchers found that 48% of the patients had inadequate functional health 
literacy, and these patients had significantly less knowledge of their disease, important lifestyle 
modifications, and essential self-management skills.  For the diabetes patients in the study, this 
finding was especially important because patients had attended formal educational classes on 
diabetes; researchers realized that their educational strategies were not optimal with the large 
number of patients with lower literacy.  However, the researchers did not find a significant 
relationship between literacy and levels of blood pressure or hemoglobin A1c.  
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 In 2002, Schillinger et. al. investigated the association between health literacy and 
diabetes outcomes in a cross-sectional study of 408 patients at two primary care clinics at a 
university- affiliated hospital in San Francisco, Calif. The patients' health literacy level was 
assessed using the short-form Test of Functional Health Literacy in Adults (s-TOFHLA).  Health 
outcomes measured in the study included patients' hemoglobin A1c level (as an indication of 
glycemic control), self-report rates of retinopathy (diabetic eye disease), depression (as 
measured by the Center for Epidemiologic Studies Depression Scale-10) and levels of social 
support (as measured by questions from the Diabetes Care Profile). These researchers found 
inadequate health literacy was independently associated with worse glycemic control and 
higher rates of retinopathy, but did not find a significant relationship between health literacy 
and the other health outcomes.   
 A recent study also reported conflicting results when studying health literacy and health 
outcomes for those with diabetes mellitus.  Osborn, Bains and Egede (2010) examined the 
relationships between health literacy, determinates of health care, and glycemic control in 125 
adults with type 2 diabetes. In this study, information collected included the patients' level of 
health literacy (utilizing the Revised Rapid Estimate of Adult Literacy in Medicine), diabetes 
knowledge and diabetes self-care (e.g. medication adherence, blood sugar testing, foot care).  
Hemoglobin A1c levels came from patients' medical records. These researchers found no direct 
relationship between health literacy and diabetes self-care or glycemic control. In a subsequent 
analysis of the data, only diabetes knowledge was found to be significantly associated with 
lower health literacy (Bains & Egede, 2011). 
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Studies on MTM programs and health outcomes for patients with diabetes mellitus 
  MTM services have shown to improve health outcomes for patients with diabetes 
mellitus.  The most notable study is the Asheville Project (Cranor, et al., 2003).  In that study, 
investigators assessed the persistence of certain health outcomes for up to five years following 
the initiation of community-based pharmaceutical care services for patients with diabetes.  
Although health literacy levels of patients were not assessed, this study demonstrated the 
benefit of pharmacy-led diabetes care program for its participants.  Again, health literacy levels 
will be established in the proposed study, adding an additional element in the evaluation of 
MTM programs for patients with chronic conditions. 
 In their quasi-experimental, longitudinal pre-post study, Cranor and colleagues studied 
the effects of patient education provided by certified diabetes educators, ongoing pharmacist 
consultations, clinical assessments, and collaborative drug therapy management with 
physicians.  The main measured outcomes were changes in hemoglobin A1c and serum lipid 
concentrations, as well as total medical utilization costs over time for 157 patients. As a result 
of these interventions, the researchers found that mean A1c levels decreased at all follow-up 
visits, with more than 50% of patients demonstrating improved levels each time. Additionally, 
more than 50% showed improvements in lipid levels. Finally, total mean direct medical costs 
decreased by $1,200 to $1,872 per patient per year compared to baseline expenditures.  
Health Literacy and Health Outcomes for Patients with Cardiovascular Disease 
 In its 2010 publication Defining and Setting National Goals for Cardiovascular Health 
Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal 
Through 2020 and Beyond (Lloyd-Jones et al., 2010), the American Heart Association (AHA) set 
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forth a new definition of cardiovascular health and outlined metrics needed to monitor health 
over time.   
 In this document, the AHA indicated that ideal cardiovascular health should be defined 
by the presence of both ideal health behaviors and ideal health factors.  Included in ideal health 
behaviors are nonsmoking, a low body mass index (BMI), certain levels of physical activity, and 
a diet within prescribed guidelines.  Although not included in the definition of ideal health 
behaviors, the AHA also recognized the importance of lipid-lowering medications and 
antihypertensive medications in reducing risks in patients with cardiovascular disease. These 
medications can allow a patient to go from "poor cardiovascular health" to "intermediate 
cardiovascular health" (as defined in the report and discussed below). The AHA also 
acknowledged the importance of monitoring medication adherence in those patients taking 
medications as better adherence has shown to improve health outcomes.    
 In outlining ideal health factors, the AHA indicated that adults should have untreated 
total cholesterol of less than 200 mg/dL, untreated blood pressure of diastolic less than 120 
over less than 80 mm Hg., and fasting blood glucose less than 100 mg/dL. Taking into 
consideration both ideal health behaviors and ideal health factors, under these guidelines 
patients can be categorized as having poor, intermediate or ideal cardiovascular health.   
 Both ideal health behaviors and ideal health factors were measured in this study. 
Measurements of health behaviors for patients with cardiovascular disease included BMI (as an 
indicator of proper nutrition) and the levels of physical activity. Adherence to medication 
regimen was also assessed as a health behavior using the Modified Morisky Scale (Morisky, et 
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al., 1986).  Health factors included measurements of cholesterol, blood pressure, and fasting 
blood glucose levels. 
Studies on health literacy, cardiovascular disease, and health behaviors 
 Perhaps the largest and most documented study dealing with health literacy and chronic 
conditions, including cardiovascular disease, has become known as the Prudential Study. As of 
2010, eight articles using the Prudential data have been published by various authors including, 
Baker, Gazmararian, Howard, and Wolf (Berkman et al., 2011).  All of these articles utilize 
information obtained from approximately 3,000 members in the Prudential Medicare plan with 
enrollees in Cleveland, Ohio; Houston, Texas; and Tampa, Fla., and south Florida. 
 Participants in the Prudential Study completed a one-hour in-person interview in their 
home. Survey items included demographics, current and past smoking behaviors, BMI 
measurement, chronic conditions (e.g. hypertension, diabetes mellitus, heart failure, and 
asthma), and self-rated physical and mental health functioning.  Patients were excluded from 
the study if it was determined they were not comfortable speaking English or Spanish, were 
blind, or had limited cognitive functioning (e.g. they did not know their address, year they were 
born or the current year or month) (Wolf, Gazmararian, & Baker, 2005).  In assessing health 
literacy, the researchers used the short version of the Test of Functional Health Literacy in 
Adults (s-TOFHLA)(Baker, Williams, Parker, Gazmararian, & Nurss, 1999). 
 Using the Prudential data, Wolf, et al. (2005) found that enrollees with inadequate 
health literacy were significantly more likely to report having heart failure and/or diabetes;  
were more likely to have limitations in instrumental activities of daily living;  and had lower 
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mental health.  However, in a subsequent study, they found no significant difference in the BMI 
of those patients with inadequate health literacy (Wolf, Gazmararian, & Baker, 2007).  
 With regard to adherence to cardiovascular medication within this same group, 
Gazmararian et al. (2006) found no significant association between health literacy levels and 
medication refills.  Although, those with inadequate health literacy skills had increased odds of 
low refill adherence compared with those with adequate health literacy skills.  
 In order to have a diet within the suggested AHA guidelines, patients need to be able to 
read and interpret food nutrition labels.  This involves not only reading skills, but basic 
numeracy skills (e.g. ability to perform basic math). In a cross-sectional study of 200 adult 
patients in an academic primary-care clinic, Rothman et al. (2006) examined the relationship of 
health literacy and the understanding of food labels. These researchers used the Rapid Estimate 
of Adult Literacy in Medicine (REALM) (Davis, et al., 1993) to measure literacy and the Wide 
Range Achievement Test (3rd ed.) (Wilkinson, 1993) to measure numeracy. The ability to 
understand food labels was assessed using a Nutrition Label Survey which the researchers 
developed for the study.  
 These researchers found that lower literacy and numeracy levels were highly correlated 
with poorer performance on the Nutrition Label Survey. In fact, even patients with higher 
literacy could have difficulties interpreting labels. In analyzing the results of their study, 
common reasons for incorrect answers included misapplication of serving size, confusion due to 
extraneous material on the label, and incorrect mathematical calculations.  
 In examining patients' ability to manage their medications, including the ability to 
identify, open, describe the dose, and describe the timing of their cardiovascular medications, 
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Kripalani, et al. (2006) found  those with inadequate health literacy significantly less likely to 
identify all of their medications, compared with those with adequate health literacy. No 
significant difference was found between inadequate health literacy and other components 
(e.g. being able to open container, indicate dose, and report timing).  
 One notable study examined a pharmacist-led intervention designed to increase 
medication adherence in patients with heart failure. In a randomized control trial, Murray, et al. 
(2007) measured adherence to those medications commonly used by such patients including 
ACE inhibitors, beta-blockers, and diuretics by patients in a university-affiliated, inner-city 
ambulatory care practice.   Medication adherence was measured several ways including self-
reported adherence (through the use of Morisky Medication Adherence Scale), refill adherence 
(using prescription records), and the use of electronic prescription container lids (devices that 
record the time and date of each opening and closing of a prescription container).  Health 
literacy, however, was not measured.  
 As was the case in this study, the pharmacists-led intervention included a medication 
history of all prescription and over-the-counter medications and dietary supplements taken by 
the patients. Additionally, the pharmacists provide patient-centered verbal instructions, written 
instructions, and medication containers containing medication category icons (e.g., a red ace of 
hearts for ACE inhibitors).  The same icon appeared in the written directions and container 
labels and lids to improve medication identification.  
 These researchers found that taking and refill adherence were greater in the 
intervention group during the nine-month intervention period, but adherence dissipated with 
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subsequent follow-up visits. However, emergency department visits and hospital admissions 
lessened and annual direct healthcare costs were lower in the intervention group. 
Studies on health literacy, cardiovascular disease, and health indicators 
 As mentioned above, health indicators for those with cardiovascular disease include the 
measurement of levels of cholesterol, blood pressure, and blood glucose.  Studies examining 
the relationship of health literacy and these indicators are also inconsistent.  (As studies 
exploring these health indictors in diabetic patients have already been outlined in Studies on 
health literacy and diabetes mellitus, above, this section will focus on studies examining 
patients with hypertension, a form of cardiovascular disease.) 
 A 2009 cross-sectional study explored the association between health literacy levels, 
hypertension control (measured by blood pressure) and knowledge (Pandit et al., 2009). In this 
study, 330 patients with hypertension were recruited from six primary care safety net clinics in 
Grand Rapids, Mich.; Chicago, Ill.; and Shreveport, La.  Participants were given the s-TOFHLA to 
access their health literacy; hypertension knowledge was measured by asking patients a series 
of questions about the characteristics and symptoms of high blood pressure.  Blood pressure 
was taken from the medical records and considered controlled if it was below 140 mmHg for 
diastolic and below 90 mmHg for systolic (or <130 mmHg/<80 mmHg for patients with diabetes 
mellitus). These researchers found lower health literacy was significantly associated with a 
lower probability of having controlled blood pressure.  
 Powers, et al. conducted a similar study with different results (2008).  For their study, 
these researchers pooled data from patient interviews performed at the time of enrollment for 
two separate randomized controlled trials to improve blood pressure control. The first 
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underlying study was the Veteran Study to Improve the Control of Hypertension, conducted at 
three VA medical primary care clinics in Durham, Va. The other participants were enrolled in 
Duke University Health Care System's Take Control of Your Blood Pressure study. To assess 
literacy, the Rapid Estimate of Adult Literacy in Medicine (REALM) (Davis, et al., 1993) was given 
to all participants and blood pressure readings were abstracted from the individuals' medical 
record.  Additionally, self-reported medication adherence was assessed using the Morisky scale 
(Morisky, et al., 1986). When looking at both groups of patients, these researchers found no 
significant difference in blood pressure control among those with lower literacy compared to 
those with higher literacy.  
 One study sought to determine if a nurse-administered, patient-tailored intervention 
could improve blood pressure control in a group of 294 veterans taking hypertension 
medication (Bosworth et al., 2005). As a part of this study, the health literacy of the patients 
was measured using the REALM (Davis, et al., 1993). If patients had lower levels of health 
literacy, their hypertension medication regimen was explained to them verbally, in effort to 
increase patients' knowledge and medication adherence.  After the first six months of the 
study, of those patients receiving the nurse-led intervention, there was no significant increase 
in patients' knowledge of hypertension or medication adherence.   
  Next, empirical literature about health literacy and patients with depression and 
anxiety will be presented. 
Health Literacy and Health Outcomes for Patients with Depression/Anxiety 
 Compared with the literature examining the relationships between health literacy and 
asthma, diabetes, and cardiovascular disease, there are fewer studies that examine health 
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literacy, depression and anxiety.  Of those studies that have explored these variables, many of 
them involve patients with HIV/AIDS (Kalichman et al., 2008; Murphy et al., 2010; Nokes et al., 
2007) or Latinos with limited English skills (Bennett, Culhane, McCollum, & Mathew, 2007; 
Coffman & Norton, 2010).  However, for purposes of this study, they have limited applicability.  
 However, there are two studies relevant to the proposed study.   Sudore, et al. (2006) 
assessed the prevalence of limited health literacy and comorbid conditions associated with 
limited health literacy, including depression.  As a part of the Health, Aging and Body 
Composition (Health ABC) Study, these researchers administered the Center for Epidemiologic 
Study Depression Scale (Radloff, 1977) to 2,512 well-functioning black and white Medicare-
eligible men and women. Drawing participants from Pittsburgh, Pa., and Memphis, Tenn., the 
health literacy level of the patients was measured using the REALM (Davis, et al., 1993).  
Information on the health status of the patients, including certain comorbid diseases such as 
cardiac disease, stroke, hypertension, and diabetes mellitus was obtained using a variety of 
data sources including clinical data obtained at yearly study examinations.   These researchers 
found that patients with lower health literacy had significantly worse health status, including 
hypertension, diabetes, obesity, and depression.  
 Conversely, as a part of the Prudential Study described earlier, Howard, Gazmararian & 
Parker (2005) explored the relationship of health literacy and self-reported depression. In their 
analysis of 3,260 managed care patients, they found no significant relationship between 
inadequate health literacy and depression.  
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Conclusion 
 The role of pharmacists in the United States is changing.  No longer are pharmacists only 
responsible for dispensing medication; now, pharmacists are required to accept responsibility 
as direct patient-care providers and enter into a more formalized relationship with their 
patients for the explicit purpose of improving patient outcomes (Cipolle, et al., 2004).  This type 
of patient-centered pharmaceutical care often includes Medication Therapy Management 
(MTM) services. Going forward, through providing MTM services, pharmacists will be in the 
position to help improve the health outcome of patients with chronic diseases such as asthma, 
diabetes mellitus, cardiovascular disease, and depression.  However, in order to do this most 
effectively, pharmacists must be aware of the health literacy level of their patients and be 
aware of the relationships between health literacy and health outcomes of those patients with 
chronic conditions. 
 To provide the requisite training for pharmacy students, educational materials about 
MTM services must be developed for pharmacy education.  These materials need to include the 
demonstration of the relationships between health literacy, MTM services and health outcomes 
of patients with asthma, diabetes mellitus, cardiovascular disease/hypertension, and 
depression/anxiety.  As will become clear in Chapter 3 below, this study's methodology was 
designed to build on existing knowledge in these areas to assist in the development of such 
materials. 
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CHAPTER 3: METHODS 
Introduction 
 This study is a secondary analysis of data previously collected as a part of an 
investigation entitled Medication Therapy Management and Health Literacy Assessment 
through Health Horizons: Manage My Medications (hereinafter, Manage My Medications).   
Started in 2008, the Manage My Medications study was part of Healthy Horizons, a health 
wellness program at Butler University in Indianapolis, Ind.  Butler University's Institutional 
Review Board approved the Manage My Medications study on August 28, 2008 (Appendix B) 
and its continuance (Appendix C).  Data from Manage My Medications was supplied to this 
investigator in the form of a de-identified dataset whereby the subjects were not identified 
either directly or through identifiers linked to the subjects.  The proposed investigation was 
submitted to Wayne State University's Human Investigation Committee for approval as 
"Exempt" (Appendix A). 
Study Site 
 In 2004, in collaboration with Butler University's College of Pharmacy and Health 
Sciences (COPHS) and Butler's Department of Human Resources, Healthy Horizons was 
established with the mission of improving the health and well-being of Butler's faculty and staff.  
As of part its mission, Healthy Horizons provides comprehensive, confidential health screening 
and patient education aimed at improving patient outcomes.  In an effort to decrease the 
overall financial impact of rising healthcare costs (including medication), in 2007, Butler 
University became self-insured.   Along with this change came an imperative to contain 
medication costs, especially for faculty and staff with chronic conditions.   
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 Armed with de-identified prescription medication claims data of Butler employees from 
the previous year, in 2008, Healthy Horizons identified the medications most frequently 
prescribed for covered employees.  Based on this data, Healthy Horizons began an MTM 
program aimed at those Butler employees taking medications for chronic conditions including 
asthma, diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety.  The 
Manage My Medications study was based on this MTM program.   
Subject Recruitment 
  Criteria for admission into Manage My Medications included: (a) being enrolled in 
Butler University's health insurance plan [including spouses and domestic partners]; (b) ability 
to sign the consent form; (c) ability to complete the study instruments with a minimum of 
assistance; and (d) taking at least one monthly prescription medication(s) for the treatment of 
asthma, diabetes, hypertension, depression/anxiety, hyperlipidemia, heartburn/GERD, 
hypothyroidism, or taking four or more chronic prescription medications.  Additionally, subjects 
had to be at least 18 years of age.  Exclusion criteria included: (a) pregnancy; (b) having utilized 
Health Horizon's services in the past twelve months; and (c) unwillingness to make the required 
visits, which included baseline and one follow-up visit after six months.  
 Persons who met the inclusion criteria were invited to participate in the study. If they 
were interested, they were provided with study details, which include information on an 
incentive gas card valued at $50.  Those who agreed to participate signed an informed consent 
form and were enrolled in the study. 
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Data Collection 
 Approximately 90 subjects were enrolled in Manage My Medications. Data were 
collected on demographic, psychosocial, and physical functioning using instruments designed 
by Healthy Horizons for the program and standard assessment instruments. Additionally, 
certain clinical tests were performed to assess and gain an understanding of the control of 
patients' disease state(s).  These data were collected at the date of enrollment in the study.  
Data collection points were baseline upon entry into the study and at six months.  This study 
only examined baseline data. 
Study Design 
 The study was a cross-sectional study to investigate associations of levels of health 
literacy and various demographic and health-related outcomes.  The research question was 
operationalized as two specific aims and corresponding research hypotheses which were 
presented in Chapter I.   
 After assessing base-line differences among health literacy levels, univariate analyses 
were conducted to determine associations between study variables utilizing the chi-squared 
test of association for categorical variables and t-tests for continuous variables.  Significance 
was set at the 5% level for a two-sided test. All testing was conducted using commercially 
available statistical software (e.g. SAS).  Finally, a logistical regression model was constructed to 
predict inadequate health literacy, using variables assessed in the previous step.  The logistical 
regression model allowed for determination to what extent any particular variable is an 
independent predictor of inadequate health literacy, controlling for other variables in the study.  
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Operationalization of the Study Variables 
 As discussed in Chapter II, the variables of interest for this study were conceptually 
derived from Health Literacy Framework (Health literacy: A prescription to end confusion, 2004) 
and The Medication Therapy Management Core Elements Service Model (American Pharmacists 
Association & National Association of Chain Drug Stores Foundation, 2008).  Within this 
framework, health literacy is identified as the study variable.  This investigation examined the 
associations of health literacy and the following factors: (a) age, gender, race, and levels of 
education; (b) clinical outcomes of asthma, diabetes mellitus, cardiovascular 
disease/hypertension and depression/anxiety, (c) medication adherence, (d) the need for 
patient education and (e) sub-optimal medication regimens.   The operationalization of the 
concepts and their associated measures are presented in Table 1.  A discussion of the 
instruments measuring these variables follows.  
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Table 1. Operationalization of Study Variables 
Operationalization of Study Variables 
Concept   Variable    Measure 
Health Literacy   Health Literacy    The Newest Vital Sign 
_____________________________________________________________________________________ 
Patient Variables  Age    Age at entry into Manage My   
        Medications 
    ___________________________________________________________ 
    Gender    Self-report of gender 
    ___________________________________________________________ 
    Race    Self-report of race/ethnicity 
    ___________________________________________________________ 
    Education   Self-report of years of formal   
        education 
_____________________________________________________________________________________ 
Health Outcomes  Asthma Control    Self-Report with Asthma   
         Control Test    
   _________________________________________________________________ 
    Diabetes Mellitus  1. Self-Report 
        2. Blood pressure 
        3. Fasting blood glucose test 
        4. Test for the following:   
             triglycerides, Total    
             cholesterol (TC), high   
             density lipoprotein (HDL),   
             and low density    
             lipoprotein (LDL).  
        5. Body Mass Index (BMI) 
    ___________________________________________________________ 
     Cardiovascular Disease  1. Self-Report 
        2. Blood Pressure 
        3. Body Mass Index (BMI) 
        4. Fasting blood glucose test  
    ___________________________________________________________ 
    Depression   Self-report with Zung    
        Depression Scale 
    ___________________________________________________________ 
    Medication Adherence            Patient Interviews and Self-Report with  
        Modified Morisky Medication Scale   
    ___________________________________________________________ 
    Patient Education  Patient interviews 
    ___________________________________________________________ 
    Optimal Medication Regimen Patient interviews 
 
 
43 
 
 
Health Literacy 
 Health literacy, as previously defined, is the degree to which individuals have the 
capacity to obtain, process and understand basic health information and services needed to 
make appropriate health decisions (Ratzan & Parker, 2000). There are multiple instruments that 
can measure health literacy.  As previously mentioned, these tests include the Rapid Estimate 
of Adult Literacy in Medicine (REALM) and the Test of Functional Health Literacy in Adults 
(TOFHLA) (Baker, et al., 1999; Davis, et al., 1993). Newer tests have been developed to assess 
health literacy, including The Newest Vital Sign (Weiss, et al., 2005). 
 For the Manage My Medications investigation, The Newest Vital Sign was used to 
measure health literacy.  One of the strengths of The Newest Vital Sign is that it tests both 
reading comprehension and the ability to make calculations (numeracy) (Mayer & Villaire, 
2007). Additionally, when compared to other tests, The Newest Vital Sign is very quick to 
administer; it takes only 3 minutes to assess health literacy.  Finally, The Newest Vital Sign is 
available in both English and Spanish. 
 The Newest Vital Sign uses the nutrition label from the back of a carton of ice cream as 
the testing vehicle.  Patients are given a copy of the nutrition label and asked six questions, 
several of which require them to make mathematical calculations.  For example, one of the 
questions asks, "If you usually eat 2500 calories in a day, what percentage of your daily value of 
calories will you be eating if you eat one serving?" To answer the question correctly, the patient 
must refer to the label, note that there are 250 calories in each serving, and divide this 250 
(calories in one serving) by 2,500 (usual calories in a day) to come up with the correct answer of 
10 percent. The total number of correct answers is the patient's health literacy score, with a 
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total possible score being 6 points. A score of 0-1 suggests high likelihood of limited literacy, a 
score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always 
indicates adequate literacy.  The Newest Vital Sign is presented in Appendix D.  For purposes of 
this study, scores were broken down into two groups: those having limited health literacy 
(scores 0-3) and those having adequate health literacy (scores 4-6) 
Patient Variables 
 Patient variables such as age, gender, race, and levels of education were assessed by 
questions posed to the patients by the interviewer/pharmacist and answers were recorded on a 
multi-page Data Collection form, which was developed by Healthy Horizons for the study.   
Existing medical conditions (e.g. asthma, diabetes, cardiovascular disease/hypertension, 
depression/anxiety) were recorded, along with the number of prescriptions per month and 
amounts spent each month on prescription medications.  Patients' health literacy score on The 
Newest Vital Sign were also recorded on the Data Collection form.  The Data Collection form is 
presented in Appendix E. 
Asthma Control 
  As mentioned earlier, asthma is an inflammatory lung disease (Poureslami, et al., 2007) 
and is considered a common chronic disorder of the airways which is characterized by, among 
other things, recurring airflow obstruction (National Heart, 2007). According to the National 
Heart, Lung and Blood Institute, effective asthma management includes the development of an 
individual treatment plan aimed at minimizing symptoms, proper use of medications, 
preventing limitations in work and other physical activity, and preventing acute attacks 
(National Heart, 2007).  However, level of asthma control is often overstated by both patients 
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and physicians, resulting in missed work or school and increased use in healthcare services 
(Nathan, 2004).  Therefore, the American Lung Association recommends everyone 12 years of 
age or older with asthma be assessed for asthma control (QualityMetric Incorporated, 2002). 
  In the Manage My Medications study, for those patients reporting being diagnosed with 
asthma, control over their condition was measured using the Asthma Control Test 
(QualityMetric Incorporated, 2002).  The Asthma Control Test (ACT) consists of a series of five 
questions, each worth 5 points, with a total possible score of 25. The questions presented in the 
ACT not only measure how often patients use asthma medications (e.g. metered-dose inhalers), 
but also assesses the functional impact of asthma on patients' daily lives.  For example, 
question number one on the ACT asks, "In the past 4 weeks, how much of the time did your 
asthma keep you from getting as much done at work, school or at home?" (emphasis supplied).  
A score of 19 points or less on the ACT indicates that a patient's asthma may not be controlled 
as well as it could be.  The Asthma Control Test is presented in Appendix F. 
Depression 
 As noted earlier, those patients with chronic conditions such as diabetes and 
cardiovascular disease may also suffer from depression.  In order to assess the rate of 
depression in those patients participating in the Manage My Medication study who reported 
being diagnosed with depression or anxiety, the researchers administered the Zung Self-Rating 
Depression Scale (Zung, 1965).  The Zung Self-Rating Depression Scale consists of 20 statements 
with a value of 1-4 correlating to each response.  Statements include: "I feel down-hearted and 
blue," "I get tired for no reason," "I feel hopeful about the future," and "I feel I am still useful 
and needed."  In response to each statement, patients indicate: "a little of the time" (1 point), 
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"some of the time" (2 points), "good part of the time" (3 points), or "most of the time" (4 
points).  Most people with depression score between 50 and 69; the highest possible score is 
80.  The Zung Self-Rating Depression Scale is presented in Appendix G. 
Medication Adherence 
 Adherence is the extent to which a person's behavior (in terms of taking medications, 
following diets, or executing lifestyle changes) coincides with medical or health advice  
(Meichenbaum & Turk, 1987). Measuring medication adherence (e.g. taking correct medication 
in the correct amount at the correct time) is an integral part of the The Medication Therapy 
Management Core Elements Service Model (American Pharmacists Association & National 
Association of Chain Drug Stores Foundation, 2008).  As such, patients' medication adherence 
was measured as a part of the Manage My Medications study.  
 For the study, medication adherence was measured of all participants using the 
Modified Morisky Scale (Morisky, et al., 1986).  Based on an earlier version, the Modified 
Morisky Scale measures a patient's motivation to take their medication and their knowledge 
about their medications.  Both of these factors help explain the intention of the patient to 
adhere to their medication regimen.  For those patients with chronic diseases, medication 
adherence is of particular importance.  
 The Modified Morisky Scale consists of six questions, with three questions measuring 
motivation and three questions measuring knowledge. For the motivation domain, each "no" 
answer (questions 1, 2 and 6) receives a score of 1 and each "yes" answer receives a score of 0.  
This provides a range of motivation scores of 0 to 3.  A score of 0 to 1 in this domain indicates 
low motivation; a score greater than 1 indicates high motivation.  For knowledge (questions 3, 4 
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and 5) a score of 0 to 1 indicates low knowledge and a score greater than 1 indicates high 
knowledge.  Motivation scores and knowledge scores are combined to determine the patient's 
overall adherence level (total possible of six points).  The Modified Morisky Scale is presented in 
Appendix H. 
Optimal Medication Regimen and Need for Patient Education 
 A significant part of any medication therapy management (MTM) program is the review 
of all of the patient's medications (both prescriptions and over-the-counter) and a 
pharmacist/patient consultation.  This is the hallmark of the patient-centered pharmaceutical 
care model. As stated earlier, MTM's are designed to improve collaboration among 
pharmacists, physicians, and other healthcare providers; enhance communication between 
patients and their healthcare team; and optimize medication use for improved patient 
outcomes (American Pharmacists Association & National Association of Chain Drug Stores 
Foundation, 2008). 
 As part of the Manage My Medications MTM program, patients were asked to bring in 
all of their prescription and over-the-counter medications when they came in for their 
scheduled interview.  A series of health screenings, including blood pressure, body mass index 
(BMI), cholesterol, and fasting blood glucose were performed on each patient.  
 During their consultation, all of the patient's medications were reviewed for the 
following potential problems: additional therapy needed, unnecessary therapy, drug 
interactions, adverse effects, insufficient dose/duration, excessive dose/duration, ineffective 
drug, administration/technique, more cost effective options, excessive use, and under use. 
 Based on the consultation, the need for health education and/or medical education was 
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also identified and patient specific education was proffered when needed. All of this 
information was recorded on the Data Collection form and kept as a part of the patient's 
confidential medical record.  All medical records were/are stored in compliance with all federal 
(e.g. HIPPA) and state laws.  
  Based on the above, a personalized health wellness plan was then developed for each 
patient, including recommendations on disease management.  Patients were given the option 
to have the results of their MTM consultation (including health screenings) sent to their 
physician(s).  Recommended changes in medication were also sent to physicians when 
requested by the patient.  Finally, a six-month follow-up appointment was scheduled for each 
patient. 
Summary 
 This chapter has presented an overview of the Medication Therapy Management and 
Health Literacy Assessment through Healthy Horizons: Manage My Medications investigation 
from which data will be used to answer the specific aims of the proposed study. Information on 
the study site, subject recruitment, data collection, study design, study variables and their 
measures has been presented.  Results of the analysis and discussion of the findings will be 
presented in following chapters. 
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CHAPTER 4: RESULTS 
Introduction 
 In this chapter, the results of the Medication Therapy Management and Health Literacy 
Assessment through Healthy Horizons: Manage My Medications investigation are presented.  
Following a description of the participants (including the health outcomes measured in this 
study), the results of the regression analyses are reported. 
Description of the Participants 
Socio-Demographics 
 A total of 90 participants took part in the MTM study. Slightly more women (N=52; 
57.78%) than men (N=38, 42.22%) participated.  With regard to race, seventy-nine of the 
participants self-identified as Caucasian (87.78%), nine participants (10.0%) self-identified as 
African-American, and two participants (2.22%) self-identified as being Hispanic.   
 The participants ranged in age from 27 to 71, with a mean age of 50.4 years (SD= + 
11.58). Participants in the study were grouped into ten-year categories. Four (4.44%) were 20-
29 years of age, ten (11.11%) were 30-39, 27 (30.0%) were 40-49 years old, 25 participants 
(27.78%) were between 50 and 59, 18 (20.0%) were 60-69, and two (2.22%) were 70 years of 
age or older.  (Age was missing for four of the participants.)  
 When considering the years of formal education, the data revealed that eight (8.89%) 
completed high school, ten (11.11%) attended some college, 28 (31.11%) completed bachelors 
degrees, 23 (25.56%) had a master's degree, and 21 (23.33%) had received a doctoral degree.  
  The socio-demographics of the study population can be found in Table 2 below.  
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Table 2. Socio-Demographics of the Study Population (N=90) 
Socio-Demographics of the Study Population (N=90) 
Characteristic        N  % 
Gender 
     Female        52  57.78 
     Male        38  42.22 
 
Race 
     African American         9  10.00 
     Caucasian        79  87.78 
     Hispanic          2      2.22 
 
Age at time of entry of study (years) 
     20-29          4               4.44 
     30-39        10  11.11 
     40-49        27  30.00 
     50-59        25  27.78 
     60-69        18  20.00 
     70+           2      2.22 
(missing ages for four participants) 
 
Highest education level completed at entry of study 
     High school          8    8.89 
     Some college                  10           11.11 
     Bachelors degree                 28  31.11 
     Masters degree                 23  25.56 
     Doctorate degree                  21  23.33 
 
Health Literacy Score 
     Limited (0-3)       10  11.11 
     Adequate (4-6)       80  88.12 
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Health Outcomes of Participants 
   As a part of the MTM program, various health outcomes of the participants were 
measured. These assessments included:  
(a) Participants' self-report of being diagnosed with a specific condition(s) (e.g. asthma, 
diabetes, hypertension);   
(b) Physiologic outcomes (e.g. blood pressure, total cholesterol, fasting blood glucose, 
body mass index); 
(c) Results of standardized self-report measures (e.g. Asthma Control Test, Zung 
Depression Scale, Morisky Medication Adherence Scale);  
(d) Patient interviews assessing the need for patient education (e.g. proper use of 
medication, medication adherence, use of monitoring devices); and 
(e) Patient interviews identifying sub-optimal drug regimens (e.g. unnecessary drug 
therapy, excessive dose/duration, additional drug therapy needed).   
The results of these assessments are discussed below by specific health outcome.  
Asthma 
 Of the 90 participants, twelve (13.3%) patients reported having being diagnosed with 
asthma.  When these twelve patients were administered the previously described Asthma 
Control Test, nine of these patients (or 75%) scored <19 points, indicating that their asthma 
may not be controlled as well at it could be.  
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Diabetes mellitus 
 Of the 90 participants in the study, 11 (12.22%) reported having been diagnosed having 
pre-diabetes and nine (10.0 %) reported having being diagnosed as having either type 1 or type 
2 diabetes mellitus.  Of those who had type 1 or type 2 diabetes mellitus, 55.6% (N=5) had both 
fasting blood glucose levels that were not in optimal range (>70 and <130 mg/dL) and low 
density lipoprotein (LDL) levels not within optimal range (>70 and 100mg/dL).  
Cardiovascular disease/hypertension 
 Over a third of the participants (N=33; 36.67%) reported having being diagnosed with 
hypertension.  Blood pressure readings were taken of these 33 patients; it was found that 27 
(81.82%) did not have their blood pressure under control (>140/90 mm Hg).  Of those patients 
not reporting having being diagnosed with hypertension, blood pressure readings indicated that 
three participants (3.33%) had pre-hypertension (> 120/90 mm Hg).  
Body mass index 
 A body mass index or BMI (as described in Chapter 1) was calculated for all participants 
in the study. A BMI <25 is considered normal, > 25 is considered overweight, and > 30 suggests 
obesity, a risk factor for diabetes mellitus and cardiovascular disease. In this study, 38.89% 
(N=35) of the participants had BMI's indicating that they were overweight and 35.56% (N=32) 
had BMI's indicating obesity.  
 Fasting blood glucose levels for those patients NOT self-reporting diagnosis of pre-diabetes or 
type 1 or 2 diabetes 
 Similar to the BMI test, all participants were administered a fasting blood glucose test, 
including those patients who did not report being diagnosed with pre-diabetes or type 1 or 2 
diabetes mellitus. For non-diabetes patients, fasting blood glucose levels of 100-125 mg/dL 
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indicate pre-diabetes, and fasting blood glucose levels of > 125 suggests diabetes. For those 
participants that did not report being diagnosed with either pre-diabetes or diabetes, 20 
(28.57%) had fasting blood glucose levels indicating pre-diabetes and 1 patient (1.43%) had a  
blood glucose level indicating diabetes mellitus.  
Dyslipidemia  
   Dyslipidemia (or abnormal cholesterol levels) is associated with diabetes mellitus and 
heart disease. Ideally, a patient's total cholesterol level should be <200 mg/dL, their high 
density lipoprotein (HDL or "good" cholesterol) should be >40 mg/dL, and their triglycerides 
should be <150 mg/dL.  With regard to low density lipoprotein (LDL or "bad" cholesterol), LDL 
levels of >130 mg/dL indicate moderate risk for cardiovascular disease and LDL levels of <100 
mg/dL indicate high risk.  
 In this study, 47 participants (52.22%) reported having been diagnosed with 
dyslipidemia (or abnormal cholesterol levels).  Of these 47 patients, 13 (27.66%) had higher 
than normal total cholesterol levels; 16 (34.0%) had both sub-optimal HDL levels and higher 
than normal triglycerides.  Twenty-one participants (44.68%) had LDL levels indicating having 
moderate risk and nine participants (19.15%) had LDL levels indicating a high risk of 
cardiovascular disease.  
Depression/anxiety 
 Of the 90 participants, 27.8% (N=25) reported having being diagnosed with depression 
or anxiety.  These patients (reporting a diagnosis of  depression or anxiety) completed the Zung 
Self-Rating Depression Scale.  Of these 25 participants, five patients (20%) scored > 50 points on 
the Zung Self-Rating Depression Scale indicating the presence of depression.  
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Adherence 
 As mentioned in Chapter 1, adherence concerns the extent to which a person's behavior 
(in terms of taking medications, following diets, or executing lifestyle changes) coincides with 
medical or health advice (Meichenbaum & Turk, 1987). Measuring medication adherence (e.g. 
taking correct medication in the correct amount at the correct time) is an integral part of The 
Medication Therapy Management Core Elements Service Model (American Pharmacists 
Association & National Association of Chain Drug Stores Foundation, 2008).  Similar to other 
tests already mentioned, all participants in the study were administered Modified Morisky 
Adherence Scale to help determine how adherent they were with their medication regimen.  Of 
the 90 participants in the study—all of whom were taking at least one medication—19 (21.11%) 
had scores indicating sub-optimal adherence to their medication regimen. 
 Need for patient education  
 As a part of this medication therapy management (MTM) study, patient interviews were 
conducted to help identify specific areas in which patients needed education regarding their 
medication and lifestyle. All participants (N=90; 100%) needed some form of patient education  
and these needs were stratified into six different categories: education about medication, 
additional information, help with disease management, help with monitoring devices, 
education about self-care, and life-style counseling. In particular, of these 90 participants, 85 
(94.44%) needed education on the proper use of their medication, while 58 patients (64.44%) 
needed additional information on adherence to their medication regimen.  Seventy-one 
(78.89%) needed help with the management of their disease(s), and 15 (16.67%) needed help 
with monitoring devices (e.g. blood glucose testing, blood pressure monitoring).  Fifty-one 
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patients (56.67%) needed education regarding self-care, while 80 (88.89%) needed counseling 
on lifestyle changes.  
Identification of sub-optimal drug regimens 
 Patient interviews done as a part of the MTM program helped identify specific problems 
with patients' medication regimens, these problems being broadly defined as "sub-optimal drug 
regimens."  Patients were asked to bring with them to the interview all medications that they 
had been prescribed along with any over-the-counter medications they were taking.  Patient 
interviews revealed that 75 study participants (83.33%) had some type of sub-optimal drug 
regimen issue.  Sub-optimal drug regimens were broken down into 12 categories. 
 Of the 75 patients found having sub-optimal drug regimens, three participants (4.0%) 
had unnecessary medications and two (2.67%) were taking ineffective drugs.  With regard to 
dose and duration of drug therapy, five participants (6.67%) had excessive dose/duration, while 
13 (17.33%) had insufficient dose/duration. Two of the patients (2.67%) were found taking 
excessive amounts of their medication(s) and nine (12.0%) were under utilizing their 
medication. Four patients (5.33%) reported adverse events relating to their drug regimens, two 
patients (2.67%) needed additional information on their medications, and five patients (6.67%) 
needed additional or follow-up laboratory monitoring.   Further, of the 75 patients with sub-
optimal drug regimens, 25.33% (N=19) were found to have exhibited ineffective administration 
of their medication and 28.0% (N=21) needed additional medications.  Finally, 46.67% (N=35) 
were prescribed medication(s) for which there was a more cost effective (cheaper) option.      
    A summary of the health outcome measures of the patient population is set forth in 
Table 3 below.  
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Table 3. Health Outcomes Measures of Patient Population (N=90) 
Health Outcomes Measures of Patient Population (N=90) 
Characteristic        N  % 
Asthma  
     Self-reporting having asthma: Yes     12   13.33 
          Asthma not controlled (< 19 Asthma Control score): Yes            9              75.0 
 
Diabetes Mellitus 
     Self-report having pre-diabetes: Yes    11     12.22 
     Self-report having type 1 or type 2 diabetes: Yes                              9  10.0 
          Blood glucose level not  
          within optimal range (>70 -  <130 mg/dL): Yes       5  55.56 
          Low density lipoprotein not within 
          optimal range(LDL) (>70 mg/dL - < 100mg/dL): Yes    5  55.56   
 
Cardiovascular Disease/Hypertension 
     Self-report having hypertension: Yes    33  36.67 
          Blood pressure not controlled (>140/90 mm Hg): Yes  27  81.82 
     Blood Pressure (for those not reporting having hypertension)        
          Pre-hypertension (> 120/90 mm Hg.): Yes     3    5.3 
 
Body Mass Index (BMI) 
     Overweight (BMI > 25 - <30 kg/m2): Yes    35  38.89   
     Obese (BMI > 30 kg/m2): Yes     32  35.56 
 
Fasting Blood Glucose (for those not reporting being 
     diagnosed with pre-diabetes or diabetes) 
     Pre-diabetes (100-125 mg/dL): Yes    20  28.57 
     Diabetes (>125 mg/dL): Yes       1    1.43 
 
Dyslipidemia (abnormal cholesterol level) 
     Self-report having dyslipidemia: Yes    47  52.22 
          Total cholesterol (> 200mg/dL): Yes     13  27.66 
          High density lipoprotein (HDL) (< 40mg/dL): Yes  16  34.0 
          Triglycerides (> 150mg/dL): Yes     16  34.0 
          Low density lipoprotein (LDL)  
               Moderate risk (<130 mg/dL): Yes     21  44.68 
               High risk (<100 mg/dL): Yes       9            19.15 
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Table 3 Health Outcomes Measures of Patient Population (N=90), cont. 
Characteristic        N  % 
 
Depression/Anxiety  
     Self-report having depression/anxiety: Yes   25  27.78 
          Evidence of depression (> 50 Zung score): Yes     5  20.0 
 
Less adherence to medication regimen (<3 Morisky score)  19  21.11 
 
Need for patient education (assessed by interview)   90  100.0 
     Proper use of medication      85  94.44 
     Medication adherence      58  64.44 
     Disease state management     71  78.89 
     Use of monitoring devices      15  16.67 
     Patient self-care       51  56.67 
     Lifestyle changes       80  88.89 
 
Sub-optimal medication regimen (assessed by interview)  75  83.33 
     Unnecessary therapy: Yes        3    4.0 
     Ineffective drug: Yes        2    2.67 
     Excessive dose/duration: Yes       5    6.67 
     Insufficient dose/duration: Yes                 13  17.33 
     Excessive use of drug: Yes        2    2.67 
     Under use of drug: Yes        9  12.0 
     Adverse events: Yes        4    5.33 
     Need for drug information: Yes       2    2.67 
     Requires additional lab monitoring: Yes      5    6.67 
     Ineffective administration technique: Yes    19  25.33 
     Additional therapy needed: Yes         21  28.0 
     Ineffective drug option (cost): Yes                                    35  46.67 
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Analysis of Research Questions by Specific Aims 
 As presented in Chapter 1, this study was guided by one research question, which was 
operationalized as three specific aims with corresponding hypotheses. The following section 
will present the analysis for each of these three specific aims.  
Specific Aim Number One 
1.  To evaluate the association of health literacy with the following demographic factors:  
gender, race, age, and level of education. 
H1a: Limited health literacy is associated with higher age and lower levels of education. 
H1b: Limited health literacy is not associated with gender or race.  
 The health literacy level of the participants was measured using the previously 
described instrument, The Newest Vital Sign.  For this study, patients were categorized by 
having limited health literacy (scoring 0-3 on The Newest Vital Sign) or having adequate health 
literacy (scoring 4-6).  Looking at the population as a whole, 11.11% (N=10) had limited health 
literacy, with the remaining 88.89 % (N=80) demonstrating scores of adequate health literacy. 
 Of the women in the study (N=52), three (5.76%) had limited health literacy, while 49 
(94.24%) had adequate health literacy.  For the males in the study (N=38), seven (18.42%) had 
limited health literacy, while 31 (81.58%) had adequate health literacy. The difference in 
proportions in the two groups was significant at the p<0.05 level (p=0.049).  
 When analyzed by race, of the nine participants who self-identified as African 
Americans, 33.33% had limited health literacy, while six (66.77%) had adequate health literacy. 
Caucasians represented 87.77% (N=79) of the study population; of this group, 8.86% (N=7) had 
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limited health literacy, while 91.14% (N=72) had adequate health literacy. (Because of the 
potential for loss of confidentiality when N<6, Hispanic participants were excluded from this 
analysis.) Limited health literacy among African Americans and Caucasians was not found to be 
statistically significant.  
 When analyzed by age, those between the ages of 20-29 years (N=4), and 30-39 (N=10), 
all (100%) had adequate health literacy.  For the group 40-49 years of age (N=27), 3.70% had 
limited health literacy; 96.30% had scores indicating adequate health literacy. For those 50-59 
years of age (N=25), 12.0% had limited health literacy, while 88.0% had adequate health 
literacy. For participants between the ages of 60-69 years (N=18), 22.22% had limited health 
literacy and 77.78% had adequate health literacy. Because of the potential for loss of 
confidentiality when n<6, those 70 and older were excluded. When analyzed by groups of ten 
years, age was not found to be statistically significant.   
 When considering the years of formal education, for those who had completed high 
school (N=8; 8.9%), 50% had limited health literacy and 50% had scores indicating adequate 
health literacy. For those with some college (N=10; 11.1%), all (100%) had adequate health 
literacy. Participants with a bachelors degree (N=28; 31.1%) were divided between 10.71% 
having limited health literacy and 89.29% having adequate health literacy. Of those with a 
masters degree (N=23; 25.6%) 4.34% had limited and 95.56% had adequate health literacy. For 
those having a doctoral degree (the highest education level of the group), 9.52% had scores 
indicating limited health literacy, while 90.48% had adequate health literacy.  Among these 
groups, there was a significant association between education level and limited health literacy 
(p=0.024).  A summary of these findings can be found in Table 4 below. 
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Table 4. Characteristics of Study Population by Health Literacy Level (N = 90) 
Characteristics of Study Population by Health Literacy Level (N = 90) 
Characteristic 
Limited 
Health 
Literacy  
Score 0- 3 
(N) 
Adequate 
Health 
Literacy 
Score 4- 6 (N) 
N 
(Total) 
% Having 
Limited Health 
Literacy 
Test 
Statistic* 
Significance** 
Total Population 10 80 90 11.11 Not Applicable 
       
Gender       
Female 3 49 52 5.76 Χ
2
 (7.00) 0.049 
Male 7 31 38 18.42   
 
Race 
African 
American 3 6 9 33.33 LR (4.04) 0.133 
Caucasian 7 72 79 8.86   
Hispanic *** *** *** ***   
 
Age entering study (years) 
20 - 29 0 4 4 0  LR (8.91) 0.113 
30 - 39 0 10 10 0   
40 - 49 1 26 27 3.70   
50 -59 3 22 25 12.0   
60 -69 4 14 18 22.22   
70+ *** *** *** ***   
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Table 4 Characteristics of Study Population by Health Literacy Level (N = 90), cont. 
Characteristic 
Limited 
Health 
Literacy 
Score 0 – 3 
(N) 
Adequate 
Health 
Literacy 
Score 4 – 6 
(N) 
N 
(Total) 
% Having 
Limited Health 
Literacy 
Test Statistic 
* 
Significance** 
 
Highest education 
level completed at 
entry of study       
High School 4 4 8 50.0   LR (11.20) 0.024 
Some College 0 10 10 0   
Bachelor Degree 3 25 28 10.71   
Masters Degree 1 22 23 4.34   
Doctoral Degree 2 21 21 9.52   
 
       
       
Note(s):  *Test statistic is either the Χ
2
 (Chi-squared Test of Association) or the LR (Likelihood Ratio); Fisher's Exact Test  
                   (2-sided) used when assumptions for Chi-squared Test were violated.   
 ** Tested at the 95% level (p-value <0.05) 
 *** Results suppressed due to having fewer than 6 individuals in a socio-demographic cell. 
 
 A separate analysis was done to understand the relationship between limited health 
literacy and age.  Participants were stratified by age into two groups: those who <50 years of 
age (N=43) and those >50 years of age (N=43) (with ages for four participants were missing 
from the data).  For those who were <50, only 2.3% had limited health literacy.  For those who 
were > 50 years, 18.6 % had limited health literacy. With these two groups, there was a 
significant association between age and limited health literacy (Χ2 =6.08; p-value= 0.02).  Figure 
4 illustrates health literacy scores by those <50 and those > 50 years of age.  
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Figure 4. Limited Health Literacy by Age Group 
Specific Aim Number Two 
2.  To evaluate the association of health literacy with clinical outcomes of patients with 
asthma, diabetes mellitus, cardiovascular disease, and depression. 
H2a: Limited health literacy is associated with clinical outcomes of asthma, diabetes 
mellitus, cardiovascular disease, and depression/anxiety.   
H2b: Limited health literacy is associated with higher body mass index (BMI), higher 
blood pressure, higher fasting blood glucose levels, and dyslipidemia.  
H2c: Limited health literacy is associated with lower medication adherence. 
H2d: Limited health literacy is associated with the need for patient education.   
H2e: Limited health literacy is associated with sub-optimal medication regimens. 
Asthma 
  Of those participants in the study who reported being diagnosed with asthma (N=12), 
two (16.67%) had limited health literacy, while ten (83.33%) had adequate health literacy.  
These same patients were administered the Asthma Control Test.  Of the asthma patients who 
scored <19 points on the Asthma Control Test (indicating that their asthma may not be 
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controlled) (N=9), two (22.22%) had limited health literacy and seven (77.78%) had adequate 
health literacy. There was no association found among either group with regard to health 
literacy levels.  
Diabetes Mellitus 
 Of the total population, 11 patients self-reported having been diagnosed with pre-
diabetes (12.22%); one person of this group (9.09%) had limited health literacy. Nine 
participants (10.0%) of the study reported being diagnosed with type 1 or type 2 diabetes. Of 
those having type 1 or type 2 diabetes 11.11% (N=1) had limited health literacy.  There was no 
association found between limited health literacy and being diagnosed with either pre-diabetes 
or type 1 or type 2 diabetes mellitus.       
 Those patients who reported being diagnosed with type 1 or type 2 diabetes were 
administered blood glucose and LDL cholesterol tests. Of the five patients whose blood glucose 
was not within optimal range (>70 - <130 mg/dL), all (100%) had adequate health literacy.  
Similarly, of those five patients whose LDL was not within optimal range (>70  - < 100 mg/dL), all 
(100%) had adequate health literacy.  
Cardiovascular Disease/Hypertension 
 As stated above, over a third of the participants (N=33; 36.67%) reported having been 
diagnosed with hypertension.  Of those 33 participants, 18.18% (N=6) had limited health 
literacy. To help gauge whether their blood pressure was under control, blood pressure 
readings were taken of these 33 patients; it was found that 27 (81.82%) did not have their 
blood pressure under control (>140/90 mm Hg).  Of this group of 27, the data revealed that 
22.22% (N=6) had limited health literacy, while 77.78% had adequate health literacy levels.    
64 
 
 
 Of those patients not reporting having being diagnosed with hypertension, blood 
pressure readings indicated that three participants (3.33%) had pre-hypertension (> 120/90 mm 
Hg).  All three of these participants (100%) had adequate health literacy. None of the groups 
mentioned in this Cardiovascular Disease/Hypertension section were statistically associated 
with limited health literacy.  
Body Mass Index 
 A body mass index (BMI) was calculated for all participants in the study and 38.89% 
(N=35) of the participants had BMI's indicating that they were overweight (BMI >25 kg/m2). Of 
this group, 14.28% (N=5) had limited health literacy, while the remaining 85.72% (N=30) had 
adequate health literacy scores.  Of those whose BMI's indicated obesity (BMI > 30 kg/m2), 
6.25% (N=32) had limited health literacy. Neither group showed a statistical association with 
health literacy. 
Fasting Blood Glucose Levels for Patients NOT Self-Reporting Diagnosis of Pre-Diabetes or Type 
1 or 2 Diabetes 
 All participants were administered a fasting blood glucose test, including those patients 
who did not report being diagnosed with pre-diabetes or type 1 or 2 diabetes mellitus. For 
patients not being diagnosed with diabetes mellitus, fasting blood glucose levels of 100-125 
mg/dL indicate pre-diabetes, and fasting blood glucose levels of > 125 suggests diabetes. For 
those participants that did not report being diagnosed with either pre-diabetes or diabetes, 20 
(28.57%) had fasting blood glucose levels indicating pre-diabetes.  Of this group 15.0% (N=3) 
had limited health literacy.  One patient (1.43%) had a blood glucose level indicating diabetes 
mellitus and this person's score on the Newest Vital Sign showed adequate health literacy.  No 
associations were found among these groups and health literacy scores.   
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Dyslipidemia  
  In this study, 47 participants (52.22%) reported having been diagnosed with 
dyslipidemia; 8.51% of these (N=4) had limited health literacy, while 91.49% had adequate 
health literacy.  Of these 47 patients, 13 (27.66%) had higher than normal total cholesterol 
levels and 15.38% of these patients (N=2) had limited health literacy. Of this same group of 47, 
16 (34.0%) had both sub-optimal HDL levels and higher than normal triglycerides.  For those 
with sub-optimal HDL levels and higher than normal triglycerides, 6.25% (N=1) had limited 
health literacy.    
 Again, of the same group of 47 participants reporting being diagnosed with 
dyslipidemia, 21 patients (44.68%) had LDL levels indicating having moderate risk for heart 
disease; 9.52% of those (N=2) had limited health literacy. Finally, those in this group showing 
high risk for cardiovascular disease (LDL <100 mg/dL) (N=9), all had scores indicating adequate 
health literacy. No associations were found among these groups and health literacy scores.  
Depression/Anxiety 
 Of the 90 participants, 27.8% (N=25) reported having being diagnosed with depression 
or anxiety.  Only one of these patients (4.0%) was found to have limited health literacy.  Of 
these 25 patients, five (20%) scored > 50 points on the Zung Self-Rating Depression Scale 
indicating the presence of depression.  All five of these members had adequate health literacy.   
Adherence 
 All participants in the study were administered Modified Morisky Adherence Scale to 
help determine how adherent they were with their medication regimen.  Of the 90 participants 
in the study—all of whom were taking at least one medication—19 (21.11%) had scores < 19 
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points on the scale, indicating sub-optimal adherence.  Of this group, 5.26% (N=1) had limited 
health literacy, the remaining 94.74% (N=18) had scores > 4 on the Newest Vital Sign indicating 
adequate health literacy. 
 Need for Patient Education  
 As mentioned above, patient interviews were conducted to help identify specific areas 
in which patients needed education, including issues involving their drug regimens and lifestyle.  
All participants (N=90; 100%) needed some form of patient education.  Eighty-five participants 
(94.44%) needed education on the proper use of their medication; it was found that 9.41% 
(N=8) of these patients had limited health literacy. Of those patients who could benefit from 
education on self-care (i.e. non-medication related improvements, like avoiding problematic 
foods) (N=51), 11.76% (N=6) had limited health literacy scores.  
 For those needing education on medication adherence (N=58; 64.44%), 12.07% (N=7) 
had limited health literacy. Of the population who could benefit from education on improved 
use of health monitoring devices (N=15;16.67%), one person (6.67%) had limited health 
literacy.  Seventy-one (78.89%) of the participants needed education on disease state 
management (e.g. seeking regular laboratory tests, monitoring blood pressure).  Of this group, 
11.26% (N=8) had scores indicating limited health literacy.   
 The last category of the need for education was on lifestyle changes, including need for 
additional physical exercise and/or weight loss. Eighty-eight participants in the study (88.89%) 
needed assistance in this area. Of these 88, the data revealed that 12.50% (N=10) of them had 
limited health literacy, while the remaining 87.50% had scores on the Newest Vital Sign 
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indicating adequate health literacy. Of all of these sub-groups within Need for Patient 
Education, no statistical significance was found with limited health literacy scores.  
Identification of Sub-Optimal Drug Regimens 
 Patient interviews also conducted as a part of this medication therapy management 
study helped identify specific problems with patients' medication regimens, with these 
problems being labeled "sub-optimal drug regimens." Patient interviews revealed that 75 study 
participants (83.33%) had some type of sub-optimal drug issue.  The sub-optimal drug regimen 
area was broken down into 12 categories. 
 Of these 75 patients having sub-optimal drug regimens, three participants (4.0%) were 
taking unnecessary medications, and 33.33% (N=1) of this group had limited health literacy.  
Two participants (2.67%) were prescribed ineffective medications; both had adequate health 
literacy.   With regard to dose and duration of drug therapy, five participants (6.67%) had drug 
regimens of excessive dose/duration,; all had adequate health literacy. On the other hand, 13 
(17.33%) patients had drug regimens involving insufficient dose or duration, of which one 
(7.69%) had limited health literacy.  
 Two of the patients (2.67%) were found taking excessive amounts of their 
medication(s); both patients had adequate health literacy scores. Of the nine patients (12.0%) 
who were under utilizing their medication, 11.11% (N=1) had limited health literacy. Four 
patients (5.33%) reported adverse events relating to their drug regimens and two patients 
(N=4; 2.67%) needed additional information on their medications.  Of both these groups, 50% 
had limited health literacy (N=2 and N=1, respectively).  The study found that five patients 
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(6.67%) needed additional or follow-up laboratory monitoring, of which 40% (N=2) had limited 
health literacy levels.     
 Further, of the 75 patients with sub-optimal drug regimens, 25.33% (N=19) were found 
to have exhibited ineffective administration of their medication, with 5.26% (N=1) 
demonstrating limited health literacy. Twenty-one patients (28.0%) were found to be in need of 
additional medications; 9.52% (N=2) of this group had limited health literacy. Finally, 46.67% 
(N=35) were prescribed medication(s) for which there was a more cost effective (cheaper) 
option.   Of these 35 patients, 2.86% (N=1) had scores showing limited health literacy.  
 Of all of these sub-groups within this Sub-Optimal Medication Regimen section, no 
statistical significance was found with limited health literacy.    
Summary of Aim Number Two 
 Limited health literacy was not found to be associated with any of the variables analyzed 
in Aim Number Two: clinical outcomes of asthma, diabetes, mellitus, cardiovascular 
disease/hypertension, and depression/anxiety; higher body mass index (BMI), higher blood 
pressure, higher fasting blood glucose levels, and dyslipidemia; lower medication adherence; 
the need for patient education; and sub-optimal medication regimens. A summary of these 
findings can be found in Table 5, below.  
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Table 5. Health Outcome Measure of Study Sample by Health Literacy Level (N = 90) 
Table 5 Health Outcome Measures of Study Sample by Health Literacy Level (N = 90) 
Characteristic 
Limited 
Health 
Literacy  
 Score 0-3 
(N) 
Adequate 
Health 
Literacy   
Score 4-6 
(N) 
N 
(Total) 
% 
Having 
Limited 
Health 
Literacy 
Test 
Statistic* 
Significance** 
Asthma 
Self-reporting having 
asthma:  Yes 
2 10 12 16.67 Χ
2
(0.433) 0.617 
Asthma not controlled 
(< 19 Asthma 
Control Score): Yes 
2 7 9 22.22 Χ
2
 (1.250) 0.261 
 
Diabetes Mellitus 
Self-report having 
pre-diabetes 
1 10 11  9.09 Χ
2
 (0.052) 1.000 
Self-report having 
type 1 or type 2 
diabetes: Yes 
1 8 9 11.11 Χ
2
 (0.000) 1.000 
Blood glucose level 
not within 
optimal range (> 
70 and < 130 
mg/dL): Yes 
0 5 5 0 Χ
2
 (1.406) 0.444 
Low density 
lipoprotein not 
within optimal 
range (LDL) (> 70 
and < 100 
mg/dL): Yes 
0 5 5 0 Χ
2
 (1.406) 0.444 
 
Cardiovascular Disease/Hypertension 
Self-report having 
hypertension: Yes 
6 27 33 18.18 Χ
2
 (2.638) 0.162 
Blood pressure not 
controlled  (>140/90 
mm Hg): Yes  
6 26 27 22.22 Χ
2
 (2.934) 0.157 
Blood Pressure (for those not reporting 
 a diagnosis of hypertension) 
Pre-Hypertension  
(> 120/90 mm 
Hg): Yes  
0 3 3 0 Χ
2
 (0.000) 1.000 
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Table 5: Health Outcome Measures of Study Sample by Health Literacy Level (N = 90), cont. 
Characteristic 
Limited 
Health 
Literacy  
Score 0-3 
(N) 
Adequate 
Health 
Literacy  
Score 4-6 
(N) 
N 
(Total) 
% 
Having 
Limited 
Health 
Literacy 
Test 
Statistic* 
Significance** 
Body Mass Index (BMI)       
Overweight (BMI > 25 
& < 30 kg/m
2
): Yes                                
5 30 35 14.28 LR (1.307)    0.520 
Obese (BMI > 30 
kg/m
2
): Yes 
2 30 32   6.25  
 
 
 
Fasting Blood Glucose  
(for those not reporting a diagnosis of  
pre-diabetes,  or diabetes) 
Pre-Diabetes ( 100 - 
125 mg/dL) 
3 17 20 15.0 LR (0.523)   0.770 
Diabetes ( > 125 
mg/dL) 
0 1 1 0   
 
Dyslipidemia 
Self-report of 
dyslipidemia: Yes 
4 43 47 8.51 X
2
 (0.674) 0.510 
Tot Cholesterol (> 
200 mg/dL): Yes 
2 11 13 15.38 X
2
 (1.091) 0.304 
HDL (< 40mg/dL): 
Yes 
1 15 16 6.25 X
2
 (0.159) 1.000 
Triglycerides (> 150 
mg/dL): Yes 
1 15 16 6.25 X
2 
(0.159) 1.000 
LDL       
Moderate Risk (<130 
mg/dL): Yes 
2 19 21 9.52 X
2
 (0.050) 1.000 
High Risk (<100 
mg/dL): Yes 
0 9 9 0 X
2 
(1.035)  0.574 
 
Depression     
Self-report having 
depression: Yes 
1 24 25 4.0 Χ
2
 (1.772) 0.273 
Evidence of 
depression (> 50 
Zung Depr’n Scale) 
0 5 5 0 Χ
2
 (0.662) 1.000 
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Table 5: Health Outcome Measures of Study Sample by Health Literacy Level (N = 90), cont. 
Characteristic 
Limited 
Health 
Literacy  
Score 0-3 
(N) 
Adequate 
Health 
Literacy  
Score 4-6 
(N) 
N 
(Total) 
% 
Having 
Limited 
Health 
Literacy 
Test 
Statistic* 
Significance** 
Less adherence to 
medication regimen  
(< 3 Mod-Morisky)  
1 18 19 5.26 Χ
2
 (0.834) 0.682 
       
Need for patient 
education 
10 80 90 11.11 Χ
2
 (0.000) 1.000 
Proper use of 
medication 
8 77 85 9.41 Χ
2
 (4.47) 0.930 
Patient self-care 6 45 51 11.76 Χ
2
 (0.051) 1.000 
Medication adherence 7 51 58 12.07 Χ
2
 (0.152) 1.000 
Use of monitoring 
devices 
1 14 15 6.66 Χ
2
 (0.360) 1.000 
Disease state 
management 
8 63 71 11.26 Χ
2
 (0.000) 1.000 
Lifestyle changes 10 70 80 12.50 Χ
2
 (1.406) 0.595 
       
Sub-optimal medication 
regimen  
7 68 75 9.33 Χ
2
 (1.440) 0.361 
Unnecessary drug 
therapy: Yes 
1 2 3 33.33   Χ
2
 (1.552) 0.301 
Ineffective drug: Yes 0 2 2 0  Χ
2
 (0.256) 1.000 
Excessive 
dose/duration: Yes 
0 5 5 0  Χ
2
 (0.662) 1.000 
Insufficient 
dose/duration: Yes 
1 12 13 7.69 Χ
2
 (0.180) 1.000 
Excessive use of drug: 
Yes 
0 2 2 0   Χ
2
 (0.256) 0.613 
Under use of drug: Yes 1 8 9 11.11 Χ
2
 (0.000) 1.000 
Adverse events: Yes 2 2 4 50.0   Χ
2
 (6.410) 0.059 
Need for drug 
information: Yes 
1 1 2 50.0   Χ
2
 (3.132) 0.211 
Requires lab 
monitoring: Yes 
2 3 5 40.0   Χ
2
 (4.474) 0.093 
Ineffective admin. 
technique: Yes 
1 17 19 5.26 Χ
2
 (0.008) 1.000 
Additional drug 
therapy needed: Yes 
2 19 21 9.52 Χ
2
 (0.070) 1.000 
Ineffective drug option 
(cost): Yes 
1 34 35 2.86 Χ
2
 (3.951) 0.082 
Note(s):  *: Test statistic is either the Χ2 (Chi-squared Test of Association) or the LR (Likelihood Ratio). 
                                        Fisher's Exact Test (2-sided) used when assumptions for Chi-squared Test were violated. 
 **: Tested at the 95% level (p-value < 0.05). 
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Specific Aim Number Three 
 3. To construct a logistical regression model to determine independent predictors of  
health literacy from among the variables considered in research questions 1 and 2, above.  
H3: Each of the following will independently predict  health  literacy: gender, age, race, 
level of education, health outcomes of asthma, diabetes mellitus, cardiovascular 
disease, and depression/anxiety, lower medication adherence, increased need for 
patient education, and sub-optimal medication regimens.  
 A logistic regression model was constructed to assess potential predictors of health 
literacy.  Candidate variables were entered into the regression model, then removed through 
backwards (conditional) step-wise regression. The variables that remained after the final step 
were: gender, age, education, self-reported diagnoses of asthma, hypertension and 
dyslipidemia.   This final model was highly significant (-2LL = 28.596; p < 0.001) and significant 
variance explained (Nagelkerke R2 = 0.869). All of these remaining variables were significant. 
These findings can be found in Table 6.  
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Table 6. Logistic Regression 
Logistic Regression 
Model: Predictors of Limited Literacy (Score 0 - 3)
1,2,3
 
95% CI for Odds Ratio 
Variable β(SE) Lower Odds Ratio Upper 
Significance 
(p-value) 
      
Gender 4.21(1.60) 2.970 67.628 1,539.77 0.008 
Age (> 50) 4.43(1.79) 2.501 83.599 2,794.00 0.013 
Education
4
 3.298(1.47) 1.515 27.069 483.767 0.025 
Asthma -5.76(1.61) 0.000 0.003 0.374 0.018 
Hypertension -3.48(1.52) 0.002 0.031 0.603 0.022 
Dyslipidemia 2.64(0.93) 13.852 1.295 148.152 0.030 
Notes: 1.  Stepwise, backwards elimination (conditional), logistic regression model was completed.  All 
variables were entered into the model with the remaining variables left after selection criteria 
were analyzed through 9 steps.  
 2. Model Assessment: -2LL = 28.596 (p-value < 0.001); Nagelkerke R
2
 = 0.869.  
 3. Overall model correctly classifies limited literacy in 91.9% of cases.  
 4. Education was recoded to be dichotomous (Graduate Degree/ Less than Graduate Degree). 
 
Summary 
 In this chapter, the statistical analysis for the study was presented.  A description of the 
participants included socio-demographics of the population and health outcomes.  Each of the 
three specific aims of the study were examined, including a regression analysis model setting 
forth the predictors of limited health literacy for the population. In the next chapter, these 
results will be discussed, along with the implications for future research and pharmacy 
education.    
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CHAPTER 5: DISCUSSION 
Introduction 
 The purpose of this study was to examine the extent to which health literacy was 
associated with different demographic factors (e.g. gender, race, educational level) in a well-
defined, self-insured population and to examine the extent to which health literacy was 
associated with clinical outcomes of those patients taking medications for certain chronic 
conditions.  Other patients were identified through this MTM study with conditions that had 
previously gone undiagnosed. 
  The primary aim of this study was to test the hypothesis that  health literacy, alone or in 
combination with other factors, was associated with certain clinical outcomes of patients with 
asthma, diabetes mellitus, cardiovascular disease/hypertension, and depression/anxiety.  
Health outcomes were measured using:  participants' self-report of diagnosis with a specific 
condition(s); physiological outcomes (e.g. blood pressure, body mass index, and fasting blood 
glucose); results of standardized self-reporting measures (e.g. Asthma Control Test, Zung 
Depression Scale); pharmacist-led patient interviews assessing the need for patient education 
(e.g. proper use of medication, use of monitoring devices); and pharmacist-led patient 
interviews identifying sub-optimal drug regimens (e.g. unnecessary drug therapy, additional 
medications needed).   
 The findings of this study will be used in the development of case studies for pharmacy 
education, supporting the inclusion of issues of health literacy into doctor of pharmacy 
(Pharm.D.) curriculum.  To adequately prepare future pharmacists, colleges of pharmacy need 
to include training on the relationships between literacy and health (Youmans & Schillinger, 
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2003).  Additionally, the findings of this study can help employers address issues associated 
with limited health literacy and chronic disease state management, thereby reducing 
healthcare costs and improving the health outcomes of their employees.    
 In this chapter, the findings of this investigation are discussed using the 
operationalization of study variables as an organizing framework. Conclusions drawn from the 
findings are presented, as are the implications for pharmacy education. Finally, the significance 
and limitations of the study are discussed and recommendations for future research are 
delineated.   
Health Literacy and Socio-Demographics of Participants 
Gender 
 Of the 90 participants in the study, there were slightly more women (57.78%) than men 
(42.22%). Of the men in the study, 18.42% had limited health literacy, scoring 0-3 on The 
Newest Vital Sign, while only 5.76% of the women in the study had similar scores. The 
difference in the proportion of these two groups was found to be statistically significant at the 
p<.05 level (p=0.049).  When a logistical regression analysis was conducted for all variables in 
the study, gender was found to be a predictor of limited health literacy. These findings were 
consistent with at least one other study that showed an association between men and lower 
literacy levels (Davis, Wolf, Bass, Tilson, et al., 2006) 
 Though the scope of the study prevents explaining this circumstance fully, two potential 
explanations come to mind. First, in the U.S. women hold primary responsibility for family 
healthcare decisions, which might be a contributing factor in women participants’ somewhat 
greater health literacy. Second, differences in limited health literacy scores between males and 
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females in this study may relate to the test instrument, The Newest Vital Sign.  Although found 
to be a valid and reliable instrument, The Newest Vital Sign tests a participant's health literacy 
by having each participant answer certain questions while examining a nutrition label of an ice 
cream. As U.S. women do much of the food shopping, men may not be as accustomed to 
reading food nutrition labels, which reduces their health literacy scores.  
Race 
 It was not surprising that in this study there were a higher number of Caucasians 
(87.78%) than any other racial group.  This could be attributed to there being few African 
American or Hispanic faculty members and staff at the study institution.   
 Of the Caucasian population, 8.86% had scores indicating limited health literacy, while 
33.33% of African Americans (N=3) had scores indicating limited heath literacy. (Health literacy 
scores for Hispanics were suppressed due to having fewer than six individuals in that socio-
demographic category.) Race was not found to be statistically associated with limited health 
literacy. The logistical regression model constructed also supported the hypothesis that race 
would not be a predictor of health literacy in this study population.   
Age 
 The average age of participants was 50 years, with ages ranging from 27 to 71 years. In 
the first analysis, participants in the study were grouped into ten-year categories.   Within these 
ten-year categories, age was not found to be associated with limited health literacy.  However, 
when ages were stratified into those who were <50 years of age and those >50 years of age, 
there was a significant association between age and limited health literacy (p-value= 0.02). This 
finding is in keeping with the general understanding that older patients are more likely to have 
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lower literacy skills (Kutner, et al., 2006) and that limited health literacy is more common in 
older people with chronic conditions, including hypertension, diabetes mellitus, obesity and 
depression (Sudore, et al., 2006).  This finding also has importance  as older Americans 
comprise an increasingly larger portion of the population and consume 2-3 times more 
medication than the general public (Davis, Wolf, Bass, Middlebrooks, et al., 2006).  Given this, 
future pharmacists need to be aware of the association of health literacy and older patients, 
especially with those with chronic conditions.  
Education 
 In looking at the data of this MTM study regarding education, for those patients whose 
highest level of formal education was high school, 50% had limited health literacy.  This finding 
was in keeping with the general understanding that those patients with lower education 
attainment often have lower literacy.   
 For those participants in the study with some college (less than a bachelors degree), 
none had limited health literacy. For those with a bachelors degree, 10.71% had limited health 
literacy; of those with a masters degree, 4.34% had limited health literacy.  Interestingly, for 
those having a doctoral degree, the number of patients with limited health literacy scores 
increased to 9.52%.  This increase seems counterintuitive, but it is consistent with other studies 
showing years of higher education do not equate to literacy skill (Kirsch, Jungeblit, Jenkins, & al, 
1993; Sudore, et al., 2006).  
 As stated earlier, there was a significant association between education level and health 
literacy.  In the logistical regression model, education was found to be predictor of health 
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literacy in this study. These findings were in support of the pertinent parts of H1a and H3 stated 
in Chapter 1. 
Health Literacy and Health Outcomes 
Asthma 
 According to one study, the lifetime economic costs for all people born in the year 2000 
who develop a diagnosis of asthma will be $7.2 billion, including $3.2 billion in medical costs 
and $4 billion in work/productivity loss (Corso & Fertig, 2009).  Given the economic impact that 
asthma can have on both the patient and the workplace, asthma was included as one of the 
chronic conditions examined in this MTM study.   Of the 90 participants, 13.33% reported being 
diagnosed with asthma, and of this group, 16.67% had limited health literacy.   
 When the Asthma Control Test was administered to patients diagnosed with asthma, 
75% had scores indicating that their asthma was not as controlled as it could be.  This 
percentage was higher than expected, perhaps indicating a need for patient education in the 
management of their disease.  Of those with sub-optimal asthma control, 22.22% of patients 
had limited health literacy.   
 Although limited health literacy was not found to be associated with either asthma 
groups, when the logistical regression model was formulated, asthma did become a predictor of 
limited health literacy.  This finding is in keeping with other studies that have shown 
associations between health literacy levels and asthma outcomes, including asthma control 
(Gazmararian, Williams, Peel, & Baker, 2003; Mancuso & Rincon, 2006).  It is also important to 
note that ethnic differences in asthma prevalence, morbidity and mortality are highly 
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correlated with poverty, urban air quality and lack of patient education (Asthma and Allergy 
Foundation of America, 2011) 
 To help their patients with asthma better manage their condition, pharmacists are in a 
position to help with asthma education.  Patient education can include helping patients identify 
those items that can trigger an asthmatic event, and reviewing patient education materials for 
readability and the inclusion of culturally sensitive content.  The latter is especially true for 
pharmacists serving urban populations, as commonly used educational materials in these 
settings have been found to be written at higher grade levels and often do not contain 
ethnically -related information (Wilson, 1996). 
Diabetes Mellitus 
 As stated earlier, given the complexity of managing diabetes mellitus, health outcomes 
for adults with diabetes mellitus are better for those who can optimally incorporate self-
management of their diseases into their daily lives (Sigurdardottir, 2005).  Diabetes care 
requires informed individuals who can seek, obtain, and comprehend information to engage in 
the management of their health (Morris, et al., 2006).   
 When entering the study, 12.22% reported having been diagnosed with pre-diabetes, 
and 10.0% reported having type 1 or type 2 diabetes mellitus. As part of this MTM study, 
fasting blood glucose tests were administered by pharmacists to all 90 participants.  As a result 
of these fasting blood glucose tests, an additional 20 patients (28.57% of the population) were 
diagnosed with pre-diabetes, and one patient was newly diagnosed with type 2 diabetes.  These 
results show the value of fasting blood glucose tests as a part of an MTM program in helping in 
the early detection of diabetes.  
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 In addition, for those nine patients diagnosed with type 1 or type 2 diabetes mellitus, 
blood glucose and cholesterol tests were performed to determine if blood glucose levels and 
lipoproteins (LDL) were in optimal range.  Of this group, 55.56% had results on both of these 
tests outside the optimal range. This is an important finding, as patients with diabetes mellitus 
should maintain proper blood glucose and LDL levels as a part of managing their chronic 
condition.  Herein, too, lies an opportunity for pharmacists to better serve patient needs and 
improve health outcomes.  
Cardiovascular Disease/Hypertension 
 Hypertension affects approximately 65 million people in the U.S. (Fields et al., 2004) and 
is a risk factor for congestive heart failure, stroke and renal disease (Neal, MacMahon, & 
Chapman, 2000).  An important element in reducing the incidence of hypertension-related 
cardiovascular disease is to increase the number of people who maintain adequate blood 
pressure control (Bosworth, et al., 2005). In spite of effective drug therapies being available, 
only 37% of hypertensive patients maintain proper blood pressure levels (Healthy people 2010: 
Understanding and improving health, 2000).   
  In this study, 33 patients (36.66%) reported being diagnosed with hypertension.  When 
these 33 patients had their blood pressure measured by pharmacists, 81.82% of these patients 
did not have adequate blood pressure control. This percentage (81.82%) is over two times 
higher than the national average.  Of those patients not reporting being previously diagnosed 
with hypertension, blood pressure measurements indicated that three participants (3.33%) 
suffered from pre-hypertension (> 120/90 mm Hg).    
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 Regarding the health literacy of the patients in these categories, 18.18% of those 
reporting being diagnosed with hypertension had limited health literacy, and of the 27 
hypertensive patients in the study whose blood pressure was less than optimal, the data 
revealed that 22.22% had limited health literacy.  All three of the participants not previously 
diagnosed with hypertension had adequate health literacy. Although limited health literacy was 
not found to be statistically significant in those diagnosed with hypertension or those found to 
have pre-hypertension, in the logistic regression model, hypertension was found to be a 
predictor of limited health literacy. 
 Pharmacists are highly accessible healthcare professionals and as such, pharmacists 
have a unique opportunity to influence the health outcomes of patients with hypertension by 
playing a more active role in assisting hypertensive patients in the management of their disease 
(Santschi, Chiolero, Burnand, Colosimo, & Paradis, 2011).  This would include monitoring the 
blood pressure of their patients, as well as (as we will see below) helping them achieve target 
cholesterol levels.  This study underscores the importance of ensuring future pharmacists 
receive specific instruction in how to take blood pressure readings, along with administering 
and interpreting other laboratory tests.  It also highlights the importance of the inclusion in 
pharmacy education of information concerning the relationship of limited health literacy and 
hypertension.     
Dyslipidemia 
 Dyslipidemia is a condition marked by abnormal concentrations of lipoproteins (or 
lipids) in the blood.  Dyslipidemia is often associated with diabetes mellitus and cardiovascular 
disease.  For purposes of this study, dyslipidemia was determined by participants' self-report of 
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being diagnosed with dyslipidemia.  The level of a patient's dyslipidemia was measured by the 
administration by pharmacists of a blood test measuring: triglycerides, total cholesterol (TC), 
high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol.  
 In this study, over half of the participants (52.22%) reported having been diagnosed 
with, and taking medication for, dyslipidemia.  Of these patients, 27.66% had higher than 
normal total cholesterol levels and 34.0% had both sub-optimal HDL levels and higher than 
normal triglycerides.  44.68% of this group had LDL levels indicating having moderate risk for 
cardiovascular disease and 19.15% had LDL levels indicating high risk for cardiovascular disease.  
These findings are in keeping with at least one other pharmacy-led study that indicated only a 
minority of patients with cardiovascular disease factors achieve targeted goals for LDL (Pearson, 
Laurora, Chu, & Kafonek, 2000). 
 When examining the prevalence of limited health literacy of these patients, only 8.51% 
of those patients diagnosed with dyslipidemia had limited health literacy. However, for those 
same patients in this group who had higher than normal total cholesterol levels, the prevalence 
of limited health literacy increased to 15.38%. For those among this group with sub-optimal 
HDL levels and higher than normal triglycerides, the number of those with limited health 
literacy was 6.25%. Of those having LDL levels showing a moderate risk of cardiovascular 
disease, 9.52% had limited health literacy levels, and interestingly, none of those who showed a 
high risk of cardiovascular disease had limited health literacy.  
 When taken individually none of these groups showed a statistically significant 
association with health literacy; however, when the logistical regression model was 
constructed, dyslipidemia was shown to be a predictor of health literacy.  
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Anxiety/Depression 
 Past studies examining the association of health literacy in patients with anxiety and 
depression have had varying results.  Of the 90 participants in this study, 27.8% reported having 
being diagnosed with depression or anxiety and having been prescribed medication to treat 
their condition.  To help gain an understanding of how effective their medication was in 
managing their condition, these patients completed the Zung Self-Rating Depression Scale.  Of 
the 25 participants having been diagnosed with depression or anxiety, 20% scored > 50 points 
on the Zung Self-Rating Depression Scale, indicating the presence of depression.  This result 
suggests that, for most of the patients in the study diagnosed with anxiety or depression, their 
medication regimen seems to have been effective.  
  Need for Patient Education and Identification of Sub-Optimal Drug Regimens 
 As mentioned in Chapter 1, the Accreditation Council for Pharmacy Education revised its 
accreditation standards in 2006 to require that schools of pharmacy include training in the 
patient-centered pharmaceutical care model.  These revisions were the result of a paradigm 
shift that has taken place in the profession as pharmacists seek to expand their role beyond the 
person responsible for the distribution of medicine.  Although this role remains an important 
part of the activities of a pharmacist (as seen in this MTM study), increasingly, pharmacists are 
taking a more active role in the clinical care of their patients.  
 Today, pharmaceutical care includes working in concert with the patient and the 
patient's other healthcare providers (e.g. physicians, nurses, physician assistants) to promote 
better health, prevent disease, and in general, help improve health outcomes.  This includes 
assessing the need for, and the provision of, appropriate patient education.  It also involves 
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pharmacists assessing, monitoring, initiating, and modifying medications to help assure that 
drug therapy regimens are safe and effective.  These activities are most aptly carried out as a 
part of an MTM program, specifically through pharmacist-lead patient interviews.   
Need for Patient Education  
  As a part of this study, patient interviews were conducted to help identify specific areas 
in which patients needed education, including issues involving their drug regimens and lifestyle.  
A full 100% of the participants needed some form of patient education.  More particularly, 
94.44% needed education on the proper use of their medication and 56.66% could benefit from 
education on self-care (i.e. non-medication related improvements, like avoiding problematic 
foods).   
 Adherence is often described as the extent to which a person's behavior (e.g. taking 
medications) coincides with medical or health advice (Meichenbaum & Turk, 1987).  Patient 
interviews revealed that 64.44% of all patients required assistance adhering to their medication 
regimen.  As medication adherence is often problematic for patients with chronic conditions, a 
separate test (e.g. Modified Morisky Scale) was administered to those in the study. On this self-
reported test, only 21.11% of the participants had scores indicating less than optimal drug 
adherence.  The reason for these conflicting results is unknown, although it seems reasonable 
to consider that patient interviews may more accurately reflect patients' adherence rates.  
 It was also found that 16.67% of the population could benefit from education on 
improving the use of their health monitoring devices, while 78.89% of the participants needed 
education on disease state management (e.g. seeking regular laboratory tests, monitoring 
blood pressure). The last educational category was the need for information on lifestyle 
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changes, which included suggestions for additional physical exercise and/or weight loss. The 
data showed that 88.89% of the participants needed additional help in this area. Importantly, 
many of these recommended changes could be implemented by patients without physician 
approval. 
 The above findings were in keeping with Body Mass Index (BMI) calculations, which 
revealed that 74.45% of the total population was either overweight or obese. Obesity remains 
an important concern of healthcare professionals as it can lead to chronic diseases such as 
diabetes mellitus and hypertension. 
 However, neither the general category of the need for patient education nor any of its 
sub-groups had a statically significant association with health literacy. BMI calculations also 
were not associated with health literacy. None of these areas were found to be predictors of 
health literacy in the logistical regression model. 
Identification of Sub-Optimal Drug Regimens 
 Patient interviews were also conducted as a part of this MTM study to help pharmacists 
identify specific problems concerning patients' medication regimens. The 1995 landmark study 
conducted by Johnson and Bootman projected that healthcare costs associated with drug 
therapy problems was projected to be $76.6 billion (Johnson & Bootman, 1995).  In 2001 when 
the study was updated, projected costs associated with drug therapy problems had increased 
to $177.6 billion (Ernst & Grizzle, 2001). In this regard, MTM programs have proven to be very 
helpful, as pharmacists can play a valuable role in identifying drug problems and increasing 
medication safety, thereby substantially reducing healthcare costs. 
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 In this study, pharmacist-led interviews revealed that 83.33% of patients had sub-
optimal drug regimens.  For purposes of analysis, the sub-optimal drug regimen category was 
broken down into 12 different types of drug-related issues.  The prevalence of these 12 issues 
are described below.   
 Of these 75 patients who had sub-optimal drug regimens, 4.0% were taking unnecessary 
medications, and 2.67% were prescribed ineffective medications.  6.67% had drug regimens of 
excess dose or duration, while 17.33% of the patients had drug regimens involving insufficient 
dose or duration. 2.67% were found taking excessive amounts of medications, while 12.0% 
were underutilizing their medications.   5.33% of the patients reported adverse events relating 
to their drug regimens and 2.67% required additional drug information. The study also found 
that 6.67% of these patients needed additional or follow-up laboratory monitoring.   
 Although these issues involved smaller segments of the population, the identification of 
these problems provided an opportunity to significantly reduce the healthcare costs associated 
with medication-related complications at this self-insured university.  
 There were a few other important findings within this group. These include that 25.33% 
of the patients exhibited ineffective administration of their medication and 28.0% were found 
to be in need of additional medication therapy to help better manage their chronic condition(s). 
Finally, 46.67% were prescribed medication(s) for which there was a more cost effective 
(cheaper) medication option.  As a part of this MTM program, patients had the option of having 
the pharmacist share this information with their physician, providing an opportunity for 
significant cost savings to both the patient and the institution.  
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 With regard to health literacy, of all of these sub-groups within this sub-optimal 
medication regimen section, no statistical significance was found with health literacy, nor were 
the sub-groups found to be a predictor of  health literacy in the logistical regression model.  
Limitations and Strengths of Study 
 Several limitations of this study should be considered.  First, these data reflect the 
results of one MTM study, conducted as a part of health wellness program at a small mid-
western university. It is possible that different findings could be found from a broader selection 
of study sites, especially those with more diverse patient populations.  The second limitation 
was the number of the participants.  Having only 90 patients taking part in the study limited 
definitive conclusions.  A third limitation was the study's design.  As it was a cross-sectional 
study, it provided information about the associations of limited health literacy and certain 
chronic diseases, but did not address causality.  Therefore, such inferences must be made with 
caution.   
 Despite these limitations, this study has significance.  Numerous medical studies have 
examined health literacy as it relates to health outcomes for patients with chronic conditions. 
Additionally, many pharmacist-led MTM studies have examined the effectiveness of MTM 
programs aimed at improving the health outcomes of these same patients.  However, what 
makes this study unique is the inclusion of health literacy assessment as a part of a MTM study. 
Despite being delineated as a part of the American Pharmacists Association and National 
Association of Drug Stores Foundation's MTM model framework, health literacy remains a 
relatively under-explored area in pharmacist-led MTM studies.  This study contributes to our 
understanding in this important area.  
88 
 
 
 This study also suggests that to be fully effective in their expanding roles, pharmacists 
need to be aware of the health literacy levels of their patients, especially those pharmacists 
more actively assisting in health care of patients with chronic conditions.  Finally, as future 
healthcare professionals, pharmacy students should receive instruction on the relationships of 
health literacy and health outcomes, including the importance of the inclusion of health literacy 
assessment as part of a comprehensive medication therapy management program. 
Implications for Future Research 
 Based on this study, several recommendations for future research can be made. This 
MTM study involved only one location which had a homogeneous population.  Other MTM 
studies should be conducted which assess the health literacy of participants, especially those 
involving more diverse populations.  If possible, data from this MTM study site should be 
aggregated with other MTM studies.  Further exploration of the differences in limited health 
literacy between women and men in these programs would also be beneficial. 
 As there was a six-month follow-up visit for patients in this study, assessments should 
be made to determine if the interventions of this pharmacist-led program resulted in 
improvements in the health outcomes of the participants.  Financial savings associated with the 
recommended changes in drug therapies should also be examined, as it would be difficult to 
imagine that there would be none following these pharmacist-led interventions.  
 Calculating both the costs associated in implementing this MTM program and the fair 
market value of the laboratory tests conducted by the pharmacists would also be useful. These 
items would help demonstrate the cost effectiveness and value added for MTM programs, 
especially for self-insured entities.  These analyses could then be shared with doctor of 
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pharmacy students, arming the students with the necessary data to assist them in effectuating 
changes in the delivery of health care, especially for patients with chronic diseases.  
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 The role of pharmacists in the U.S. continues to evolve.  Pharmacists are now being 
trained to be drug information specialists and medication counselors.  More than ever, 
pharmacists are helping patients with chronic conditions manage their diseases through the use 
of medication therapy management programs. As a part of these programs, it is important that 
pharmacists are aware of what effect their patients' health literacy level may have on health 
outcomes.   
 The purpose of this study was to examine the extent to which health literacy was 
associated with different demographic factors and the extent to which health literacy was 
associated with clinical outcomes for patients with asthma, diabetes mellitus, cardiovascular 
disease/hypertension, and depression/anxiety in a well-defined, self-insured university 
population. 
 To answer the research question, data from the pharmacist-led program "Medication 
Therapy Management and Health Literacy Assessment through Health Horizons: Manage My 
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Medications" was analyzed.   Data were collected on demographic, psychosocial, and physical 
functioning using standard assessment instruments and patient interviews.  Additionally, 
certain clinical tests were performed to assess and gain an understanding of the control of 
patients' disease state(s).  Data was collected at two points – upon entering the program and at 
six months.  This study only examined baseline data. 
 For this study, patients were categorized by having either limited health literacy or 
adequate health literacy.  Of the 90 participants enrolled, 11.11% had limited health literacy; 
88.89% demonstrated adequate health literacy. The results revealed that at the p<0.05 level, 
men were significantly more likely to have limited health literacy than women (p=0.049).  Age 
was also found to be associated with health literacy.  When divided in groups <50 years of age 
and > 50, there was a significant association between health literacy and age (p=0.02).  When 
considering years of formal education, patients with lower levels of educational had greater 
lower health literacy.   Among different educational levels, there was a significant association 
between health literacy and education (p=0.024). 
 When considered individually, health literacy was not found to be associated with any  
clinical outcomes of asthma, diabetes, mellitus, cardiovascular disease/hypertension, and 
depression/anxiety; higher body mass index (BMI), higher blood pressure, higher fasting blood 
glucose levels, and dyslipidemia; lower medication adherence; the need for patient education; 
and sub-optimal medication regimens. 
 However, when a logistic regression model was constructed, self-reported diagnoses of 
asthma, hypertension and dyslipidemia were found associated with heath literacy along with 
gender, age, and education.   The final model was highly significant (p < 0.001).  
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 The results of this study demonstrate the need for more research on the role of health 
literacy assessment in medication therapy management programs.  Likewise, information on 
the relationship between health literacy, patient demographics, and health outcomes of 
patients with chronic conditions should be included in pharmacy education curriculum. 
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